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'Ihe agouti locus, located on chromosome 2 of the house mouse 
(nrus Im.lSCUlus), functions in the complex regulation of pigment 
synthesis . 'Ihe COITiplexity of its regulato:ry role is revealed through 
the aberrations that become manifest when a mutation, specifically 
the lethal yellow (AY) mutation, occurs at the agouti locus . '!he 
lethal yellow mutation is associated with an alteration in pigment 
synthesis, onset of obesity at approximately 12 0 days, and an 
increased susceptibility to cancer. Based on the putatvie 
relationship between cancer and inanunity, this mutation may be 
correlated with altered inanune mechanisms. This correlation was 
investigated by comparing a delayed-type hypersensitiivity (DTH) 
response to dinitrofluorobenzene (DNFB) _, in vivo ht.nnoral immunity to 
sheep red blood cell ( SRBC) , and in vitro lyrnphocyt� reactivity of 
C57BI..I6J AYja mice with congeneic aja controls . Responses were 
compared between 42-day-old and 120-day-old mice to determine the 
correlation, if any, between altered inanuni ty and age-oriset ?besi ty. 
Data indicate that the AY mutation is directly liked to a supressed 
DIH response and , to some extent, a decreased reactivity to mitogen­
induced lymphocyte proliferation . Obesity appears to play a role in 
the alteration in humoral inanuni ty as demonstrated by an enhanced 
anti-SRBC IgM response and suppressed antibody-fanning cell (AFC) 
response to SRBC . Finally, serum from obese yellow ( AYja) mice was 
markedly suppressive in in vitro lymphocyte proliferation assays. 
n .A. 'Dle kJruti IDcus 
2 
'!he agouti locus , ubiquitous in most orders of manunalia ,  is 
located on chrcmosarne 2 of Mus musculus (59) . In the wildtype 
(agouti) mouse, this locus regulates the synthesis of two pigments , 
phaeornelanin arrl emnelanin which produce yellow and black hair color , 
respectively . 'Ihe agouti genotype (A/A or +/+) is phenotypically 
expressed as a hair bearing a black shaft, a yellow band , and a black 
tip . 
Eumelanin and phaeomelanin are synthesized in melanosomes 
which are small granules synthesized by the endoplasmic reticulum and 
Golgi complexes of melanocytes (85) . 'Ihe regulation of the synthesis 
of these two pigments is the product of many compleX interactions . 
'!he switch in melanin synthesis from phaeamelan.ln to eumelanin 
appears to be correlated with an increase in tyrosinase ?ictivity (7). 
Tyrosinase ftmctions in the oxidation. of tyrosine to dopachrame , a 
melanin precursor. 'Ihree isozymes of tyrosinase have been identi � 
fied which vary according to their attached carbohydrates (56). 
Glycosylation of tyrosinase may therefore determine the type of 
melanin synthesized ( 85) . 'Ihe switch to eurnelanin synthesis may 
also be controlled by a pituitaJ:y honrone known as melanoCyte 
stintulating honnone (MSH) (56, 66) . '!his honrone stintulates 
tyrosinase activity through cyclic AMP (cAMP). However, tyrosinase 
activity is not solely regulated by MSH and is believed to be 
controlled by a ntnnber of other factors V?hich can also operate 
through a cAMP messenger system (7). 'Ihat cyclic AMP is central to 
this conversion is irxticated by its ability to switch eurnelanin 
synthesis to phaeomelanin (66) . 
II.A.l. Regulatory Role of the Agait.i !.Deus 
3 
The mode of action iinparted by the agouti locus in the 
regulation of pigment synthesis is unknown . However, at least five 
regulatocy mechanisms, not necessarily distinct, have been proposed 
for its actions. First, the agouti locus is bel ieved to indireCtly 
influence pigment production by the melanocyte through a follicular 
regulatory factor. Melanocytes from black mice, prcx:lucing only 
emnelanin, will begin to prcduce phaeomelanin when transplanted into 
the hair follicles of yellow mice. '!he reciprocal transplant , yellow 
to black, results in a shift in pigment synthesis from phaeomelanin 
to emnelanin ( 65) . '!bus the microenvironment of the melanocyte 
strongly influences its pigment prcx:luction. 
Secondly, the type of pigment prcx:luced appears to be 
dependent upon the ratio of an unidentified · regulatory parameter' 
putatively produced by the agouti locus and the bulb mass {19). A 
propOsed model suggests that phaeomelanin is prcx:luced when the ratio 
of regulatory parameter to bulb roass exceeds a critical threshold. 
As a corollary to this, eurnelanin is synthesized when this ratio 
falls below the critical threshold ( 19) . 
4 
'Ihird ,  a correlation between the structure of the rnelanosorne 
and the type of pigment produced is noted. Melanosomes that contain 
eumelanin are rod-shaped an:i those that contain phaeomelanin are 
spherical ( 65) • 'Ihus , this suggests that the agouti locus plays a 
regulato:cy role in the detennination of the ultrastructure of 
melanosomes (65) . 
Fourth, the agouti locus is postulated to be involved with 
the regulation of tyrosinase . A mutation at the agouti locus (AY) 
which is· marked by the synthesis of phaeamelanin only has been 
correlated with the absence of two of the three isozymic forms of 
tyrosinase (56) • 
Finally, Wolff (82)  postulates that the regulato:cy factor (s)  
controlled by the agouti ,locus may focuS its action on the endo­
plasmic reticulum, a major site of protein synthesis . He speculates 
that alterations in this region may affect a nuinber of functions 
throughout the metabolic network (82 ) . 
II . A. 2 .  Genetic Linkage of the Agait.:i with !nm.Jrx)regulato:cy GeneS 
ChrornosOlre 2 mapping reveals a close association between . the 
agouti locus and several immunoregulato:cy gene sequences . This 
region is rerrarkably analogous to the Major Histocompatibility 
Complex (MHC) of chroioosOme i7 in the murine system (54 ) . · The MHC 
region is composed of a tightly linked series of genes , often 
referred to as H-2 , which encodes for a nmnber of traits of 
immunological significance including the histocompatibilitY antigens 
(62), tmnor virus susceptibility and immune responsiveness (50) . 
'lbree distinct classes of genes have been mapped in the MHC 
region of Clrroirosane 17 . 'Ihese are Class I (histocompatibility) , 
Class II (immune response) , and Class III (complement) genes. 
5 
Briefly, antigens coded for by the Class I region were first 
recognized as the prinru:y antigens involved in graft rejection, a 
measure of histocompatibility, and are thus often referred to as 
transplantation antigens. 'lbree families of histocompatibility genes 
have been identified in this class and are referred to as K, D, · 
and L (70) . 'Ihese histocompatibility loci code for histocompati­
bility antigens which are located on all nucleated cells and are 
found in the highest concentration on the membranes of B cell, T 
cells, and macrophages (70). 'Ihese histocompatibility antigens allow 
for the differentiation of self from non-self antigens thus enabling 
the detection and subsequent elimination of aberrant cells by the 
immune· system. Certain T-cell subsets only recognize �tigen when 
presented in association with Class I antigens. This is referred to 
as MHC restriction. 
Individual animals differ in their immunologic responsive­
ness to specific antigens. '!he ability to resp::>nd and/ or the 
intensity of the response is inherited in a Mendelian fashion (6). 
'!his ability has been ascribed to immune resp::>nse or Ir genes. 
'Ihese genes code for the strength of the serological response to T­
dependent antigens ( 6, 63) . In other words, Ir genes regulate the 
interaction of antigen-presenting cells and the T-cell. '!he Ir gene 
products, referred to as Ia antigens, are predominantly expressed on 
cell membranes of antigen presenting cells (B lymphcx:ytes, macro-· 
phages, and dendritic cells) and are rarely expressed on T lympho­
cytes (63 ) . 'Ihus far, only a few structural Ia antigens have been 
·identified. '!his presents a pel:plexing situation in that irmnuno-
lo;rists have been unable to explain how a relative paucity of irmnune 
response genes can control the magnitude of irmnune responses to an 
enonnous variety of antigens (53 )  . 
6 
inle most COITIIOOnly recognized Ir genes are linked to the 
histocompatibility antigens of the H-2 region on chromosome 17 and 
are commonly referred to as the Class II MHC genes ( 62 ) . Similar to 
Class I MHC restriction, Class· II MHC restriction also occurs . For 
example, interaction between helper T-cells ani either macrophages or 
B cells occurs only �f the helper T-cells possess specific receptors 
for the Class II antigens on the surface of antigen-presenting 
cells (70) . As a result, antigen presenting cells and T.-cells must 
have the same haplotype in order for T-cell activation to occur ( 53) . 
Class II genes also control the proliferation, differentiation and 
effector ftmctions of regulatocy T-cells which ultimately control the 
B-cell response through the amplification or suppression of T-cell 
subsets (70). 
Considerable attention to the MHC region has occurred as a 
result qf the rapidity of graft rejection when the antigens· coded by 
the H-2 region in donor and recipient mice are mismatched. However, 
even when tllese antigens were compatible, �ft rejection continued 
to occur, thus irx:licating that other lcx:i on other chromosomes were 
also fotll'rl to control graft sw::vi val. These lcx:i are referred to as 
non-H-2 lcx:i and ccxie for non-H-2, or "minor histocompatibility" 
antigens. Disparity between non-H-2 lcx:i may lead to graft 
rejection, albeit usually with less intensity than H-2 misnatched 
mice (51) . Nevertheless, the potency of these non-H-2 lcx:i should 
not be underestimated: the multiplicity of their effects can often 
result in graft rejection with magnitudes similar to that obse:rved 
with H-2 disparity (51) . 'Ihese non-H-2 lcx:i may also be as poly­
morphic as the MHC (51) . 
7 
Significantly, several non-H-2 histocompatibility loci are 
located in the fifth linkage group of chromosome 2 near the agouti 
lcx:us. Backcrossing of .strain B10 .LP indicates that the H-3 
histocompatibility locus is linked to the agouti allele with a 
mapping distance of 10 . 3  centimorgans (eM) in males and 20 . 5  eM in 
females. A second weaker histocompatibility locus, H-13., is linked 
closer to the agouti locus than the H-3 locus. Additional 
histocompatibility loci are also believed to be linked to the H-3· and 
H-13 loci (54 ) . 
As obse:rved with other histocompatibility loci (54) , the 
histoCompatibility genes of chrcmosorne 2 are in close proximity with. 
ilmnune response genes , specifically the Ir-2 locus which has beeii 
shown to control the immune response to an erythroCyte antigen . . This 
lcx:us appears to be linked ·to the H-3jH-13 complex. Furthennore, the 
Ir-2 locus 
.
(denoted as such to differentiate it from the Ir-1 locus 
8 
of the
· 
MHC) has been detennined to be linked to the agouti locus with 
a distance of 20 map · units (20 , 54 ) . A further similarity with the H-
2 region of c.hroioosame 17 is that chromosane 2 contains gene 
sequences which code for both lymphocyte surface markers , i.e . Ly-4 
and Ly-ml1 , and a complement cauponent (CS) ( 11 , 54 ) . Cllrcrriosome 2 
has additional innnunologic illlportance in that the B-2-microglobulin 
gene is found in this linkage group (11) . B-2-microglobulin is a 
small polypeptide of unknown function that is noncovalently linked to 
the ClasS I histocompatibility antigens (70) and has amino acid and 
structural homology with regions of the immunoglobulin mole-
cules (60 ,  67) . 
II .A. 3. Mutations at the Agaiti I.ocus 
'Ihe complexity of the agouti locus is demonstrated by the 
wide array of effects that mutations at the agooti locus impart . One 
such mutation is the viable yellow (A vy) mutation . '!his mutation is 
associated with an alteration in regulation of the hair color 
pattern . Additionally, it is associated with an increased suscep.:.. 
tibility toward obesity and neoplasms (40 , 84)  . . '!his mutation is .a 
valuable model for the study of the possible correlation between the 
microenvirorunent and the expression of the agouti locus because it 
allows for the segregation of two phenotypes within a genotype� 
While homozygous viable yellow (A  vy /A vy) are yelloW , the hetero­
zygotes (Avy/a) may demonstrate two different phenotypes even though 
they are genetically identical . 'Ihese two phenotypes are referred to 
9 
as mottled yellow and pseudoagouti. Only the mottled yellow become 
obese while the pseudoagouti remain lean. 'Ihese phenotypic 
differences may result from the envirorune.ntal modulation of the 
regulatory processes of the mutant gene product ( 85) . Investigators 
have postulated that the envirornnent of the reprOductive tract of the 
dam plays a major role in the phenotypic differentiation of the Avy/a 
embryos (85)  • 
At least seventeen distinct alleles have been identified at 
the agouti locus (56) . In addition to the viable yellow mutation 
which results in different pigmentation patterrlS, there is the l�thal 
yellow mutation. '!his mutation, which is quite similar to but more 
severe than the viable yellow was first described by CUenot in 1905 
as referenced by Heston (_34 ) arrl is designated AY. A number of 
manifestations are assoc::::iated with this allele, of which the most 
visible effect is the coat color. As a result of this mutation, hair 
bulb melancx:ytes of strain C57BI/61 mice produce only phaeomelanin 
resulting in a coat of yellow hair. 'ihis mutation does not seem to 
involve an impainnent inherent with the melanocyte. When MSH or · 
cyclic AMP is added to organ culture of skin from yellow mice, 
eurnelanin synthesis is induced ( 66) • '!his suggests · that the agouti 
locus ·may impart its action on regulatocy mechanisms involving the 
-MSH-cAMP system. 
II.B. 'Ihe Ietllal YellCYN CAYl M.Itation 
10 
'Ihe A'l nutation, unlike the viable yellow, is a recessive 
lethal mutation with haoozygous blastocysts dying on the fifth day 
after conception (44 ) . '!his is apparently due to a failure in 
:ill'lplantation to the uterine wall or to intrinsic defects within AY;AY 
embryos (23 ) . However, mice heterozygous (AY/a) for the lethal 
yellow gene are viable. For this reason, the A'l mutation is 
maintained in a congeneic strain by inbreeding with the nonagouti 
(black) � designated as aja. 'Ibis strain is genetically 
identical to the AY;a at all loci within the genome except at the 
agouti locus. With the exception of the viable yellow, the AY gene 
is dominant to all other alleles identified at this locus (56). Like 
the viable yellow, A'l is .associated with obesity and an increased 
susceptibility tc:Mards cancer. 
II.B.l. �lecular Sbxties of the M.Itatiat 
While the secondary physiological alterations imparted by the 
lethal yellow mutation are well known, the direct action of the gene 
on the gene product affected by this mutation has not been eluci-:­
dated. 'Ihe search for possible aberrations in protein function as a 
result of this yellow mutation has been complicated by the diverse 
effects of genomic backgrourxi. 'Ihe effects of the yellow ·mutation 
depeni upon the residual backgrourrl genome (82) . For example, 
effects of background genome have been demonstrated in the study of 
embryonic survival in the AY;a mouse where decreased sw:vival of 
female A'l;a embcyos is noted in A'l;a dams . '!his decreased survival 
of yellow embcyos, however, was only obsel:Ved in one of the strains 
studied (83 ) and ,  therefore, cannot be directly related to the 
nn.1tation. Incidentally, selective loss of yellow heterozygotes in 
either yellow or black dams did not occur in strain C57BI/fJ mice, 
the strain to be used in this research (24 ) . 
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Since wide varieties of aberrations are associated with the 
AY allele, the lethal yellow mutation is speculated to interact with 
a regulatory mechanism ( 19)  . In an effort to identify a polypeptide 
that may be under the direct influence of the agouti gene , a number 
of key metabolic enzymes were assayed for activity within_ yellow mice 
from different genomic backgrourrls (84) . 'Ihese enzymes included 
those of glycogen and fat metabolism . Of the enzymes tested , 
cytoplasmic malic enzyme deroc>nstrated the closest relation to the 
prinm:y effect of the AY gene. 'Ihis enzyme is intimately involved in 
fatty acid synthesis . Aberrations in activity of this EmZyrne may 
cause the excessive fatty acid deposition obsel:Ved in the lethal 
yellow mouse (84 ) . other enzymes studied were different between · 
yellow and non-yellow mice but these differences were restricted . to 
specific strains (84 ) . 
II. B. 2.  CJJesity arrl HoDional Involvenent 
_
'Ihe lethal yellow mutation is associated with an age onset 
obesity linked by_ an increase in. adipose tissue and an increase in 
muscular arrl skeletal growth (38) . onset of obesity is correlated 
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with an increased food intake arrl reduced energy requirements ( 38) . 
Obesity is considered to be a physiological state associated with 
aberrations in honnone production arrl metabolism (47) . The role of 
honoonal involvement arrl obesity (38 ) has led to the study of 
honoonal differences in the yellow nnJSe . However, data indicate 
that possible honoonal aberrations do not appear to be causally 
related to .the onset of obesity. While adrenalectomy reduced the 
weight gain of the yellow llD.l.Se, the reduction was not enough to 
consider adrenal glarrl abnonnalities to be the prinary lesion in the 
induction of obesity ( 42 ) . F\lrthenoore, removal of the pituitary 
glarrl in the yellow mouse did not prevent obesity (85)  . Based on 
these data , the age-associated· onset of obesity does not appear to 
result from honnonal imbalances but seems to be a result of some 
other metabolic aberration. 
In related experiments, yellow and non ... yellow mice were 
placed in parabiosis to detect possible metabolic aberrations that 
rray alter growth characteristics of either member of the pair. While 
this did not influence weight gain nor growth of either the yellow or 
non-yellow nouse, results :in:licated that the AY allele exerted an 
effect on the amount of nonfat dry liver residue. 'Ihus, researchers 
hypothesize that altered metabolic, and possibly ho:rmonal imbalanceS, 
affect the liver metabolism (81) . other metabolic aberrations noted 
included a significant elevation in hexokinase activity in the adult 
yellow toouse (30)  . Additionally, glucose metabolism is impaired ; 
yellow mice display more than twice the amount ·of blood Stigar than 
that of their lean li ttennates . '!his is also correlated with 
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capillary dilatation arxi degranulation of beta cells in the pancreas 
of the yellow IOOUSe (30) . 
II.B.2 .a.  Honnonal Implications in Reproductive Failure 
In contrast to the lack of correlation noted previously 
between adrenalectomy, hypophysectomy and honnonal influences on 
obesity in the yellow mouse, evidence of possible honnonal lesions 
caused by this mutation has been presented. Data indicate an 
association between infertility and the AY nn.1tation in the lethal 
yellow female mouse. These mice have fewer litters and stop 
reprcxiucing at an earlier age than their congeneic black litter-
mate (26) . Depressed ovulation rates were partially restored by 
exogenous gonadotropins administered to these mice (26) . Further-
more, AY ovaries grafted to a nonyellow host maintained their 
reproductive capacity longer than ovaries in the yellow host (25). 
'nlese data suggest that reproductive failure is not due to defective 
ovaries and may suggest endocrine lesions within the hypothalomo-· 
pituitary axis (25) . 
II. B •. 3. SUsceptibility to carx::er 
In addition to aberrant pigmentation and obesity, the lethal 
yellow mutation is also 
.
associated with an increased susceptibility 
to cancer . Heston (34 ) was the first to demonstrate that· the AY 
gene, or some factor segregating with the gene, increased the 
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susceptibility to 20-methylcholanthrene imuced tumorigenesis of 
pulloonary ttnoors in yellow mice. SUbsequently, the lethal yellow 
gene was proven to be associated with an increased susceptibility to 
spontaneous pu.lloonary tumors (37) , hepatomas, mammary tlnnors ( 39) and 
irrluced neoplasms of the skin (77 ) . Deringer (15 )  also reported a 
susceptibility to reticular neoplasms. '!his increased susceptibility 
to mammary ttnoors ,  hepatomas ani reticular neoplasms is demonstrated 
by an earlier onset in the yellow toouse as compared to the onset in 
agouti mice ( 15) • . 
While the ,causative factor associated with the development of 
cancer is not known , investigators suggest that the factor involved 
with this increased tumor susceptibility is associated with an 
increase in body weight (.39 , 55 ) . By inCreasing the weight of 
nonyellow mice with gold-thioglucose injections ani restricting the 
food intake of the lethal yellow IOOUSe, the difference in tumor 
susceptibility between these mice was elinri..nated (38 ) . 
Hormonal changes are sanetimeS associated with an increased 
risk in selected neoplastic disorders ( 4 7)  • '!he effects of possible 
hol:'llDnal aberrations ani ·cancer susceptibility in the yellow mouse 
has been studied to a limited extent . Male hypophysectomized AY mice 
denonstrate a significantly reduced incidence of spontaneous 
hepatomas (35) . While the inhibitory effect of this condition is not 
known , it is speculated .that inhibition may be due· to a decreased 
ftmction of the testes (35) suggesting a pituitacy involvement of 
this mutation. 
II.C. Inmmoloqic TmlicatialS of the Iethal YellOVI Mutation 
II. C.1. Aberrations in i:amme furx±i.cn 
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'lhe association of the lethal yellow gene with an increased 
susceptibility towards cancer suggests another manifestation among 
the broad milieu of effects of this mutation . A putative relation­
ship between cancer arrl an bnpaired imrmme system is well docu­
mented. '!he close linkage association of the agouti locus with many 
imnrunoregulato:cy sequences ani the increased susceptibility to 
cancer displayed by the lethal yellow mutation implicates a possible 
involverrent of this mutation in inunune dysfimction . 
rr. c. 2. carx:er am IDmmi ty 
'!he correlation between cancer am aberrations in imnruni ty is 
inconclusive . While the cause ani effect pattern has not been finnly 
established , an association between cancer and immunosuppression has 
been obsel:ved. In many malignancies including leukemia ,. myeloma , 
Hodgkin • s disease , and solid ttnnors, a suppression in cellular 
imnrunity has been demonstrated (29). With the exception of Hodgkin's 
disease, ht..nnoral imnruni ty is also suppressed in these cases ( 29) � 
'Ihe detennination that a person with a primary imnrunodeficiency 
disease has a hurrlredfold increase in the incidence of cancer 
provides evidence for the causal effect of imnrunosuppression in 
cancer (1) . F\lrthenrore , the risk of cancer may be increased 10 to 
100 times for patients receiving. imnrunosuppressive dl:ugs to prevent 
graft rejection (1) . On the basis of these studies , a thea:ry has 
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been proposed regarding the role of the imrm.me system in eliminating 
malignant cells as a part of its imrm.me surveillance function. 'Ihi.s 
theory postulates that the immune system recognizes arrl resporrls to 
turoc>r specific antigens of transfonned malignant cells arrl eliminates 
them (18) . 
Evidence against the aforementioned theory has also been 
presented. Detection of turoc>r-specific antigens and the subsequent 
use of imrm.motherapy in many cancers have been unsuccessful (58 ) . If 
cancer is the result of immunosuppression, tissue specificity of 
cancer would not be expected . However, cancers observed in trans­
plant recipients terrl to be located within the lymphoid system or in 
the skin . Furthennore, cancers of the lung, breast ,  colon , and 
bladder occur in no greater frequency in imrm.mosuppressed individuals 
than in the general population (46) . 'Ihese studies indicate that the 
association between cancer ani inmune dysfunction is more tenuous 
than previously believed. 
'!he possibility of a genetic predisposition towards cancer 
has received considerable attention. A statistical correlation 
· 
between histocompatibility antigens and susceptibility to neoplasia 
has Peen noted. '!his susceptibility may be influenced by genetic 
factors in the host. 'Ihese may be regulated by the host 1 s 
immunological responsiveness to specific tmnor antigens and are 
closely associated with . genes controlling the host 1 s histo­
canpatibility antigens (50). Certain tmnors have respondEd to 
genetic selection ani occur in high percentages in specific inbred 
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strains ( 36) . For example , inherited susceptibility to virally­
irrluced leukemias has been shown to be linked to the mouse H-2 locus 
(17). '!his susceptibility may involve a complex relationship between 
histocanpatiliility antigens am inunune responsiveness (50, 68) . 
To re-emphasize, the role of the inmrune system in response to 
neoplasia is uncertain. cancer susceptibility appears to be under 
the control of genetics through the inability to respond to certain 
tumor antigens or susceptibility may be due to general .imnuno­
suppression, as observed in immunologically suppressed transplant 
patients . '!he lethal yellow rrouse provides an exciting model for the 
elucidation of the role of immunology in neoplasia . '!he association 
of the AY gene with cancer susceptibility suggests a genetic tendency 
towards cancer. However'- the mutation is associated with age-onset 
obesity. As will be described, obesity is associated with 
inmrunosuppression. 
II. C. 3. Cbesity arrl Illmmity 
Obesity is postulated to play a role in inmrune dysfunction . 
Obese mice have been deroc>nstrated to show an ilnpaired cellular 
inmrunity as detennined by aberrations in certain cell types and their 
functions (9, 52). Genetically obese C57BII6J objob mice contain 
fewer mononuclear cells arxi 'Ihy 1. 2 positive lymphocytes than their 
lean controls (9 ) . Cytotoxic activity of spleen cells and absolute 
spleen size were fourxi to be significantly reduced in these obese 
animals (10) . In contrast� natural killer (NK) activity ahd 
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antibody-deperxient cellular cytotoxicity are increased (9). other 
investigators obseJ::ved that obese mice resporrl significantly less to 
the skin contactant, picryl chloride when compared to lean mice (52 ). 
'!his impainnent of cellular immunity, however, is reversible (9, 52) • 
In vitro priming of lymphocytes eradicated any differences in 
activity between obese arrl lean mice which irrlicates that impaired 
ilmnune function nay be a consequence of an abnonnal environment in 
obese anbnals ( 10) • 
'!here are conflicting reports on the effect of obesity on 
humoral, or B-cell, activity. Meade, et. al. (52) obseJ::ved that 
obesity does not seem to depress antibody fonnation against sheep red 
blood cells (SRBC). In contrast, <llarrlra (9) obseJ::ved a significant 
reduction in plaque fonni.ng cells (PFC) to SRBC (9). '!he marked 
decrease appears to be predominantly of the IgG isotype and thtis may 
be due to a deficiency of helper T-cells (9 ) . 
'!he cause of the altered imnunocompetency in o� mice is 
not krlown . However, envirornnental factors seem to be involved as 
indicated by the reversibility of the impairment in in vitro cu1....: 
ture (52). In addition to metabolic aberration such as hyperphagia 
ani hyperglycemia, errlocrine alterations are also observed in 
genetically obese mice (9) • For exalll'le, genetically obese mice 
display hyperinsulinemia, elevated levels of adrenocorticOtrophic 
honoone_ (ACIH) arrl increased B-errlorphins (9 ) . Honnones have � 
shown to interfere with lymphocyte proliferation and function (45) 
where optimal levels of honnone seem to be essential in maintaining 
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immunologic homeostasis. For example, insulin enhances antibody 
synthesis by B-lyztplocytes. HCMever, high concentrations of insulin 
inhibit Interleukin-2 irrluced lyztplocyte proliferation and suppresses 
henolytic plaque-fanning cells to sheep red blood cells (57 ) . 
Likewise , Acm increases mitogen-induced lymphocyte proliferation 
(45) , but suppresses antibcxiy prOduction (57 ) . Obesity is also 
believed to cause depressed growth honnone responses to various 
challenges arrl possible suppression of prolactin responses ( 4 7) . The 
requirement of lyztplocytes for growth ho:nnone is readily observed 
during in vitro se:nnn free culture (57 ) . In vivo, the ntnnber of 
circulating B- and T-cells in adult mice have been found to be 
proportional to the level of growth honnone ( 45) . Another honnone, 
prolactin, stimulates be� antibcxiy production by B-cells and 
delayed-type hypersensitivity to dinit.rochlorobenzene by T-cells 
( 45) • 'Ihus, the endocrine system and the irnnrune system appear to be 
interrelated and proper functioning of immunocompetent cells appears 
to be urrler direct honnonal influence·. 
II. C. 4 .  :R:lssible Correlation Between h3aiti IDcus arrl Inmmity . 
A limited number of investigations of possible aberrations 
involving i.mmunity in the lethal yellow m::ruse have been conducted. 
Investigators propose that certain genes known to be associated with 
high tumor susceptibility may also be associated with low immunologic 
responsiveness. '!hey demonstrated that the spleen cells of the 
nonagouti (a/a) genotype are more reactive in a graft versUs host 
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reaction than are those of the congeneic 13 or Avy mice. This was 
detronstrated by splenic irrlices followirg allografts of AY , A vy, ·or 
aja splenocytes into YBR Af or C57BI/fJ Avy F1 hybrids (YBR X 
C57Bl/10 or C57BIIfJ X blO.BR F1 , respectively). Reciprocal skin 
grafts were also perfonned between Af or Avy ani aja. Results 
irrlicate no apparent histocompatibility differences between AY or Avy 
mice and their congeneic aja mouse . 'Iherefore, they suggest that the 
quantitative differences in the .inmtune response is not associated 
with differences at a histocompatibility locus (21). 
Studies of the effect of the physiologic envirornnent of· the 
.inmtune response have been corrlucted using the viable yellow model. 
'Ihese investigations centered arourrl the effects of phenotypic 
expression of the Avy genotype. '!heir 1:-esul.ts indicate partitioning 
of the differences in inm.mological responsiveness according to 
phenotype. When compared to lean genetically identical pseudoagouti 
Avy/a mice, obese Avy/a mice exhibit decreased antibody .response to a 
T-cell deperrlent irnrm.mogen, enhanced . antibody responses to a· T-cell 
iroeperrlent inununogen (Type II pneUIOOCOCCal polysaccharide) and 
increased levels of. serum IgA. Pseudoagouti arrl nonagouti mice . 
respon:ied similarly (59) . '!hey concluded tbat alterations in immune 
function are the result of phenotypic expression of the Avy genotype. 
II.D. Cbiective 
'!he purpose of this investigation was to detennine if 
aberrations in immunity are part of the primary lesion of the lethal 
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yellow mutation arxl to subsequently ascertain. if a correlation exists 
between :iJnmunoincompetency arxl age-onset obesity. Humoral and cell­
trediated inununity were assessed in the lethal yellow mouse at six 
weeks arrl at 120 days, the age at which obesity becomes ap-
parent (23,26). 'lhese data were compared with those of lean 
congeneic black age-matched littennates. 'Ihe well-established tests 
of cellular imnunity include in vivo assessment of delayed type 
hypersensitivity (DIH) and in vitro lymphocyte responses to T-cell 
mitogen5 (29 ) . Hurcoral i.nununity was assessed in vivo by both 
enumerating antibody fanning cells (AFC) and measuring antigen 
specific i.nununoglobulin levels and detennined in vitro by IPS­
induced lymphocyte proliferation of B-cells . 
II.E. Rationale 
'lhe increased susceptibility towards cancer in the lethal 
yellow m:>use strongly suggests an aberration in i.nunune respon­
siveness . Evidence for this correlation has been presented through 
experinents demonstrating altered i.nununity in this tumor susceptible 
rrouse line,  as well as the viable yellow m:>use. However, aber- . 
rations in the ilmnune response were obsel:ved to separate with 
Iilenotype in the viable yellow mouse . 'Ibis obse:rvation implicates 
envirornnental physiologic factors as the cause of these aberrations. 
'!his is. further substantiated by data available on i.nununocompetency 
in the obese mouse :naiel . However, studies on the i.nununocompetency 
in the lethal yellow mice, a more severe mutation , versus the effect 
of their physiologic environment have not been conducted . 
II. F.  Measme:te�It of Inmmocc ••• eterx:y 
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'!he .immune system involves all of the physiologic mechanisms 
that alla.v the OOdy to defend itself from constituents that appear 
foreign including viruses , bacteria, arxi abnonnal cells . To simplify 
discussion, the .immune response is divided into two components , 
humoral an:i cell-mediated. Ha.vever, these divisions are not absolute 
in that these two facets are intimately involved in the regulation of 
each other. '!he hurooral ann of specific inununity is B-cell mediated 
in which the effector cells of the response are believed to be 
derived from the bone marrow ( 5)  . '!his facet of the inunune response 
is canmonly associated with inununoglobulins, or antibody . Inununity 
afforded by this ann of the hmume response is transferrable through 
sen.nn . Inununoglobulins are glycoproteins produced by the B-cell in 
response to stimulation by antigen. 'Ihese inununoglobulins bind 
specifically to the antigenic confonnation that induced its Synthesis 
ani subsequently allows the body to neutralize the possible effects 
of the antigen. Five classes of these glycoproteins differing in 
structural as well as biological properties have been identified and 
are denoted IgG , IgM, IgA , IgE , a.rx:i IgD . IgG is found in highest 
concentration in the blood ani is effective in opsonization and the 
eventual lysis of cellular antigen. IgM, the largest inununoglobulin, 
appears in the secorxi highest concentration in the blood· and is most 
efficient in the activation of a mechanism leading to celT lysis . 
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IgA is the nDSt prevalent antiJ:x:dy in bodily secretions . IgE , found 
in very low concentrations , is involved in Type I hypersensitivity 
reactions . IgD is fourrl primarily on the cell membrane on B-cells . 
Cell-mediate:i inmunity is typically associated with rejection 
of abnonnal cells within the body. SUch cells include tumor cells , 
virally-infected cells , ani grafts . 'lhe effector cells in this 
process , derived from bone marrow stem-cells , are referred as T-cells 
and are differentiate:i within the thymus. Transfer of T-cell 
mediated irranunity can only be accomplished by the transfer of T­
lymphocytes .  
ll . F. l . Assessment of Cell�ted Inmmity (CMI) 
ll . F . l . a . Delayed-type Hypersensitivity 
Delayed-type hypersensitivity assays are utilized for the 
evaluation of the cellular or T-cell ann of the specific immune 
response . Hypersensitivity is an exaggerated reaction of immuno­
logic specificity to an antigen or hapten. An initial , or 
sensitizing, dose of antigen or hapten is required before hyper­
sensitivity reactions can be invoked (2 )  . '!he exaggerated reaction 
is initiated, after a waiting period of 5 to 10 days (2) , when a 
subsequent exposure to the sensitizing antigen is encountered. 
Subsequent exposure is referred to as the challenge . While inununo­
logic in nature, hypersensitivities are generally detrimental to the 
host rather than protective. 
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Hypersensitivity reactions may be classified as immediate or 
delayed depending upon the time of onset after antigenic challenge 
and the requirement for antibody or T-cells ( 2)  . Ilmnediate 
hypersensitivity develops within seconds or minutes after challenge 
and is antibody-rned.iated.· Due to involvement of antiJ::xxly, immediate 
hypersensitivity can be passively transferred through sennn. In 
contrast, delayed-type hypersensitivity (DIH) is a hypersensitivity 
reaction that is characterized by a relatively slow onset when 
compared to imrnediate hypersensitivity . Additionally, DIH cannot be 
transferred from one animal to another by serum but is adoptively 
transferred through the transfer of T lymphocytes . A IJIH reaction is 
initiated by T-cells which subsequently recruit a large population of 
monocytes and rnacrophages · to the area where antigen is present. 
Hence , this reaction is often referred to as T-cell mediated 
hypersensitivity. 
Inunediate-type hypersensitivity is subdivided into three 
types on the basis of immunopathology . ( 2) . Type 1 hypersensitivity 
is IgE dependent and involves the participation of mast cells and · 
basophils . IgE produced from a sensitizing dose of antigen binds to 
an Fe receptor for this immunoglobulin located on these two cell­
types . Cross-linking of two bound IgE by antigen results in 
degranulation releasing histamine, heparin and other chemical 
mediators . 'Ihese lead to vasodilation, smooth muscle contraction , 
hypotension, shortness of breath, · edema, increased vascular per­
meability , and sometimes death . Type II, or cytotoxic, 
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hypersensitivity is IgG mediated and involves a complement-dependent 
cytolysis . '!his reaction is significant in mismatched blood 
transfusions and hemolytic diseases of newborns . Type III , or inunune 
COIT'plex hypersensitivity , is the result of antigen-antibody complexes 
leading to the ·activation of the complement cascade . Subsequently , 
chemotactic factors for neutrophils are released . '!his neutrophil 
infiltration leads to local tissue destruction (71)  . 
Four types of DIH reactions have been described ( 61)  . 'Ihese 
include the Jones-Mote reaction , contact hypersensitivity , tuber..: 
culin-type hypersensitivity , and granulomatous hypersensitivity . Of 
these four, the first three occur within 72 hours after antigen 
challenge with the fourth type developing aver a period of several 
weeks. 
The Jones-Mote reaction is maximal at 24 hours . '!his 
manifestation is characterized by the infiltration of basophiles to 
the area immediately under the epidermis after an intradermal 
challenge to an antigen . This is known as cutaneous basophilic 
hypersensitivity (CBH) . The Jones-Mote response is strongly 
regulated by cyclophosphamide-sensitive lymphocytes ( 61 )  . 
Contact hypersensitivity is maximal at 48 hours after antigen 
challenge . Predominantly an epidermal reaction , it is characterized . 
by a mononuclear cell infiltrate accompanied by edema of the 
epidermis (61 )  . Many of the antigens responsible for the initiation 
of this reaction are haptenes which covalently or non-covalently 
conjugate to self proteins . The antigen presenting cell in this 
conjugate to self proteins . '!he antigen presenting cell in this 
reaction is the Iangerhans cell (61) . 
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'!he third type of DIH reaction is the tuberculin reaction. 
Like contact hypersensitivity, its maximal reactivity occurs 48-72 
hours after antigen dlallenge. Histologically, it is characterized 
bY an extensive infiltration of lymphocytes and rracrophages . 
'!he fourth, arxi pertlaps the most deleterious DIH res{X>nse is 
the granulatomas reaction. Granulata(nas occur as a long-tenn effect 
of DIH . Macrophages migrating to the site of the DIH reaction become 
activated. 'Ihese, in tunl , release factors that cause lymphocyte 
activation . This process leads to giant cells such as those obse:rved 
in tuberculosis . '!he net effect of this reaction is the release of 
lysosomal enzymes arxi cytotoxic factors that lead to further tissue 
damage ( 32 ) . 
TI . F. 1.b. Measurement of DIH 
A number of methods have been ·described to detect a om · 
response in the murine m:rlel . A carmnon method is the fCX)tpad 
reaction. '!his is . pe:donned by injecting antigen into a metatarsal 
pad of the hindfCX)t ( 13) '!he visible reaction, as indicated by . 
irduration, will appear at 6 hours after challenge, peak at 18-24 
hours , an::l recede after 48 hours (13) . As with most types . of om · 
reactions, thickening of the skin occurs at the site of antigen . 
injection. '!be thickness of the challenged foot is measured with a 
caliper an::l · compared to the thickness of the control fCX)t. Another 
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test of IJIH reactivity is the skin test involving the intracutaneous 
injection of the antigen. '!he subsequent reaction parallels the 
footpad reaction. DIH begins 6 to 8 hours and peaks at 18-48 hours . 
Erythema is Ul"lCCl'[U''C)n in DIH skin reactions in the mouse and cellular 
infiltration l1U.lSt be detennined by touch ( 13 ) . Problems arise in the 
murine model because nr>use skin is thin and leakage into subcutaneous 
tissues occur ( 3) • A third test is the percutaneous skin test 
reaction which is primarily used to detennine contact hyper­
sensitivity. A measured volume of chemical , or antigen, is applied 
to a confined, shaven area of the IOC>use . The subsequent response 
parallels that obseved in the skin test reaction . A common test 
site is the ear . This is advantageous in that the ear does not need 
to be shaved and thus reduces irritation. Reactions have been 
traditionally measured in the same manner as the skin test reaction 
in which the ear lobes are measured with a caliper. Skin thickness 
is correlated with the intensity of the reaction ( 13) . Unlike the 
previous two tests , this reaction is not complicated by an accom­
panyirg inunediate type hypersensitivity ( 13) . 
Quantitation of DIH by measuring skin or footpad thickness is 
difficult to perfonn when responses are marginal . since swelling or 
increased thickness may also be due to edema rather than from 
cellular infiltration (74 )  such methods may be incorrectly· inter- · 
preted . . Since DTH is primarily the result of the infiltration of a 
rapidly proliferating monocyte population, the use of radioisotopic 
� precursors provides a very sensitive assay for DIH responses . 
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'!his assay measures the anomt of labeled monocytes that infiltrate 
at the site of antigen challenge (74 ) .  125r-uDR is typically used 
for labelling. ;rncre.asoo labelling efficiEmcy can be achieved by 
increasing the titre of availability of the label or by decreasing the 
size of the competing thymidine pool ( 41)  • 'Ihe thymidine pool can be 
decreased by injecting small annmts of fluorodeoxyuridine (Fro) . , 
FilJ blocks thymidine synthesis from deoxyuridine by binding and , 
thus , inhibiting the enzyme required _for thymidine synthesis (41) . 
Amplification of in vivo DIH reactions may also be potentiated by the 
use of cyclophosphamide. DIH is suppressed by blocking factors that 
occur when antibody complexes with antigen (48 ) . cyclophosphamide 
has long-lasting deleterious effects of the B-cell ann of the llmnune 
system thus blocking the modulating effect of B-cells on DIH (73) . 
II . F. 2 .  Assessment of HlmDral. Illmmity 
Measurement of specific antibody is dependent upon the 
affinity of the antigen-antil:xxiy interaction. Amplification of this 
ilmnunologic reaction can occur by the activation of the humoral 
cuuponent known as complement. Complement is a ·general tem denoting 
a cascade of proteins activated in the presence of bound antibody 
that ieads to the eventual lysis of cells. Hence, B-lymphocytes 
producing antibody to the cellular antigen in the presence of com­
plement will lead to fonnation of plaques as a result of cellular 
lysis . '!his has been the fourrlation for a method of enumerating 
antil:xxiy-prodUcing B-cells known as the Jerne Plaque Assay or the 
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henDlytic plaque assay. '!his is an ilnportant tool for the in vitro 
assessment of in vivo immunoreactivity. '!he host is sensitized with 
an antigen, i . e. SRBC, which invokes antibody production by the a­
lymphocyte. Lymphocytes are subsequently isolated arxi cultured in 
the presence of the cellular antigen arx:l complement .  'Ihe antibody 
isOtype IgM is the rrost efficient activator of the complement 
cascade. 'Ihus l'L¥:)S't plaques that fonn in this assay are due to this 
isotype. other lymphocytes producing different innmmoglobulin 
isotypes can be quantified through the addition of species-specific 
anti-isotype serum .  
Another assay used to assess htnnaral inummity involves 
evaluation of the level of antibody in the serum .  Enzyme immune­
assays (EIA) are conunonly ·utilized in the detennination of antibody 
levels . EIA ' s incorporate the specificity of the antigen-antibody 
reaction with the efficiency of an enzyme . While many variations of 
EIA are perfonned, the basic component is an enzyme-labelled 
antibody . Specificity is provided by the antibody. Fonnation of the 
antigen-antibody complex is detected by the enzynatic conversion of a 
substrate by the antibody-bound enzyme . '!he enzyme utilized is 
chosen such that substrate conversion involves a colorimetric change . 
'lhus, colorimetric conversion is an indirect measure of the amount of 
antibody bourrl to its specific antigen. 
ll .F. J . . Mitogen Irxbn=rl � Proliferation 
In vitro mitogen-induced lymphocyte proliferation is used as 
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both a diagnostic ani research tool to measure lymphocyte reactivity . . 
Clinically, it has been used to detect ani measure congenital and · 
acquired inmrunologic deficiencies as well as to rronitor the effects 
of various imrnunosuppressi ves arxi immunotherapeutic treatments ( 64 ) . 
Mitogens are substances that activate lymphocytes without regard to 
antigenic specificity. In other words , mitogens added to cultures of 
nonsensitized lymphocytes will initiate blast transfonnation and 
proliferation. Cross-linking of the 1l\itogen to surface molecules on 
the lymphocyte is believed to pe:rturt> the cell membrane and thus · 
stimulate the lymphocyte to divide (33 ) . 
Certain lectins ani bacterial en:iotoxins are known to have 
mitogenic effects on lymphocytes. 'Ihese mitogens specifically bind to 
certain sugar groups or glycoproteins located on the lymphocyte 
membrane ( 33 ) . For example, the plant lectin, Concanavalin A 
{Con A) , binds to glycoproteins containing -mannosyl groups . 
Another plant lectin, phytohemmaglutinin, binds N-acetyl­
galactosamine ( 4 )  . 'Ihese birxiing specificities have penni tted the 
evaluation of specific subclasses of lymphocytes . It has been 
detennined that murine lymphocytes bearing the ly 1 surface antigen 
respom to concanavalin A ( 51)  . '!his antigen is found both on 
urrlifferentiated T lymphocytes and on differentiated helper 
T cells (72) . Fhytohemmaglutinin (FHA) stimulates T-cells bearing 
the ly 1 ; 2 , 3  surface antigen, or undifferentiated T-cells { 51 , 72 ) . 
While Con A and FHA demonstrate specificity toward T-cells , the 
ba�ial muponent , lipopolysaccharide (LPS) is a B-cell 
mitogen (33 ) . 
While these tests represent only a sample of the numerous 
tests available to measure immunocanpetency, these will permit the 
detection of aberrations that may be prevalent within the broad 
spectrum of iimnune response mechanisms present in the body. In 
recapitulation, the intent of this research is to conpare the cell­
mediated ilmnunity and hUlOOral .immunicy between the lethal yellow 
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(AY/a) . mouse and its congeneic black (aja) litte:rnate at two poirits 
in their lifecycle. Cell-mediated immunity will by assessed through 
an in vivo radioisotopic DIH assay and through an in vitro prolif­
eration response to the T-cell mitogens , PHA and Con A. HtnnOral 
immunity will be measured · in vivo through a direct hemolytic plaque 
assay for the quantitation of specific B-cell activity to sheep red 
blood cells and through the detennination of specific antibody levels 
in serum utilizing an indirect enzyme ilmnunoassay . Furthennore , in 
vitro non-specific B-cell activity will be assayed by the proli­
ferative activity of B-cells to LPS .  Combined , these tests will 
allow the detennination of ilmnunologic alterations as a result of the 
lethal yellow mutation. 
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III.A. Mice 
Female C57BI/6J A'/ja (lethal yellow) ani congeneic aja 
(black) mice, obtained from Jackson Laboratories (Bay Harbor , Maine) 
were maintained in a colony at South � state University, 
Brookings . Mice were sustained in 462 c:m2 cages at no more than 8 
mice per cage. Focxi (Wayne Breeder Blox) and water were provided ad 
libitum. 
All experiments were perfonned on the lethal yellow AY ja mice 
ani canpared with congeneic black aja mice . 'nle effects of age-onset 
obesity was perfonned by canparing these mice at both 120 days 
(approxilnately 17 weeks) with 42 days ( 6  week) of age . Hence each 
series of experiments were perfonned on four groups of mice, 42-day­
old A'l;a, 42-day-old aja ,  120-day-old A'l;a , and 120-day-old aja 
female mice . 
m .B. Delaved-Type Hypersensitivity 
'lWo days prior to sensitization, all miee were inj ected 
subcutaneously with 150 nqjkg 1:xxly weight of cyclophOSphamide (Sigma ,  
St. Louis , Missouri) . '!he lower abdomen and both hind flanks on all 
mice were shaven on the following day. Forty-eight hours following 
injection of cyclophosphamide, six AY;a arx:i six aja mice from each 
age group were sensitized with a topical application of a 10 rrgjml 
· solution of 2 , 4-dinitrofluorobenzene (rnFB) (Sigma ,  St. louis) 
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dissolved in a 1: 1 mixture of olive oil : acetone. 'IWenty-five ul were 
applied to each of three shaven areas . Six control mice from each of 
the four groups were painted with an equivalent volume of the olive 
oil : acetone solvent. '!he concentration and voltnne of the sensitizing 
agent were detennined by a preliminary pilot study. Five days 
follc:Ming sensitization, all mice were challenged with a topical 
application of 5 ul CNFB ( 10 ngjml) on the right ear lobe. An 
equivalent volume of the solvent was painted on the left ear of all 
mice. .Ten hours follc:Ming the challenge , all mice were inj ected 
intraperitoneally with 100 ul 5-fluoro-2-deoxyuridine (10-6 M in 
physiologic saline) (Signa ,  St. louis) . 'IWenty minutes later, mice 
were injected intraperitoneally with 1 . 92 uci of 125r-deoxyuridine 
(689 uCi/mL) (Amersham, Arlington Heights , IL) . After sixteen hours , 
mice were tenninated via ceJ:.Vical dislocation. Ears were excised and 
placed in Wheaton omnivials (American Scientific Products , ) . Gamma 
emissions were counted and recorded on a Gamma 4000 gamma · counter 
(Beckman, I:rvine, califonria) • Data were re{X)rted as a ratio of cpm 
in right earjcpm in left ear. 
m . c. rn vivo Hurrnral Inmmity 
m . c. 1. 
m . C. l.a.  Primary Response. 
Forty-two-day-old and 120-day-old C57BI/6J AYja and aja 
female mice were injected intraperitoneally with 0 . 25 ml washed SRBC 
· ( 4 X 109 cells/ml) in sterile physiologic saline . Immune 
. .  
responsiveness against SREC was detennined on days 4 , 5 , 6  and 7 
following :inununization. 
m . c. 1 .b. Secondazy Response. 
Forty-two-day-old am 120-day-old C57BI/6J AY fa am a; a 
female mice were injected three times at weekly int:Ellvals with 0 . 25 
ml · washed SRBC ( 4 X 109 SRBC/ml) in physiologic saline. Immune 
responsiveness against SREC was assayed 4 , 5 , 6  and 7 days after the 
third immunization. 
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. On the preselected assay days after both prilnary and 
secorda.ry :inununization, each nnJSe was weighed and exsanguinated via 
the subclavian artecy. '!he spleen ani thymus were excised and 
weighed. Serum was separated from the clotted blocxi via centri­
fugation at 500 X g on a SOJ:Vall Rl' 6000 refrigerated centrifuge and 
stored at -20°c. '!he spleens were subsequently used for the 
emnneration of plaque-fanning cells. 
m . C. 2 .  Assay of Hmooral Inm.mi.ty 
III. C. 2 .a.  Plagye-forming Cells 
'Ihe spleens from immunized mice were removed ' as described aoo 
passed through a size 50 stainless steel mesh screen (Small Parts ,  
Inc. , Miami, Florida) • Spleenocytes were washed in 10 ml RFMI 1640 
(Sigma) and centrifuged at 200 X g in a So:rvall Rl' 6000 centrifuge 
using an H-1000 rotor. cells were resuspended in one milliliter of 
RR1I 1640 supplemented with 10% SRBc adsorbed, heat inactiva�ed fetal 
'calf serum (FCS) (Gibco Iaboratories , Grani Island, New York) . 
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Forty microliters of each Spleen suspension was placed in 
disposable blood dilution vials (American Scientific Products , McGraw 
Park, Illinois) containing 20 ml physiologic saline for quantitation 
of leukocytes . Red blcxxi cells were lysed with five drops of Zap­
Isotron II (Coulter Diagnostics , Inc .  ) arrl leukocyte counts were 
perfonned using a Model MHR Coulter Counter (Coulter Electronics , 
Hialeah, Florida) . 
Plaque-fanning cells (PFC) were detennined according to the 
CUnningham-Szenberg modification of the Jerne Plaque Assay ( 14 1 43 ) . 
Seventy-five microliters of the suspended splenocytes were added to a 
mixture containing 125 ul SRBC ( 1  X 109 cells/ml in RIM! with 10% 
FCS) 1 25 ul SREC adsorbed guinea pig complement ( Gibco) 1 and 25 ul 
RIM! .  Forty microliters of this cell suspension was added to each of 
three coverslip dlambers on a microscope slide. Evaporation was 
prevented by sealing the edges of the coverslip chamber with heat­
liquified petrolemn jelly. Slides were incubated thirty minutes at 
37°C. Plaque-fanning cells were enl.IIlle"rated on an Olympus microscope 
(leeds , Minneapolis , Minnesota) usirg a 4X objective (40X final 
magnification) . '!he number of plaque-fanning colonies per 106 spleen 
cells were deter.m.ined. 
m.C. 2 .b. Enzyme Immunoassay (EIA) 
m . C. 2 .b. i.  Preparation of SRBC Membranes . Membranes from 
SRBC were prepared through osmotic lysis and release of hetnc?9lobin 
according to the procedure outlined by Hanahan and Ekholm ( 28 )  using 
hypotonic phosphate buffer prepared as described by Dcrlge, 
et. al .  ( 16) . Following the final wash, membranes were pooled and · 
susperrled in 20 n()sM ( 5 . 9 IrM Na2mo4 , 1 . 2  nM NaH2ro4 phosphate 
buffer) , pH 7 .  4 , arrl stored at -2oOc. 
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Protein concentrations were detennined using Biorad Protein 
Assay (Biorad Laboratories, Ric.hnx:>n::l, california) and 8CA Protein 
Assay (Pierce , Rockford, Illinois) against a standard CLU:Ve of bovine 
sennn albumin ,  Fraction V (Boehringer Mannheim Biochemicals , 
Iniianapc)lis, m) • '!he average concentrations determined from the 
two separate assays was detennined. 
m .c. 2 .b. ii. EIA. '!hawed SRBC membranes were solubilized 
in 0. 1% sodium dodecyl sulfate (SOO) (Sigma) . 
Wells of a 96-well flat-bottaned IImnulon 1 Removawell Strips 
(Dynatech laboratories , Alexarxlria, VA) were coated with 100 ul of a 
1:  500 dilution of solubilized SRBC membranes ( 1 .  25 rrg protein/ml) 
using 0 .  05 M carbonate buffer at pH 9 .  6 .  Control wells were coated 
with carbonate buffer, pH 9 . 6 . Plates. were incubated ovemight in a 
humidity chamber at 4°C. 
Plates were washed three times with 300 uL 20mM Tris (Tris 
hydroxymethyl aminanethane) (Sigma) buffer, pH 7 .  4 with 0 .  05% '!Ween 
20 (Sigma) • Unbourxi sites in the wells were blocked by the addition 
of two hundred microliters of 0 . 1% gelatin (Knox Gelatine, Inc . , 
Englewood Cliffs, New Jersey) in Tris buffer without '!Ween 20 . 
Following incubation at room temperature for one hour, the plates 
· were washed three times with 300 uL Tween 20 supplemented Tris buffer 
' ·  
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(Trisjtween) • One hurxired microliters of serum diluted in Trisjtween 
with 0 . 1% RIA (radioi.nmmoassay) grade bovine albumin (Sigma) were 
added in triplicate to both SRB: coated wells am control wells . 
Primary inm.me serum was diluted 1 : 25 for ooth IgG and IgM assays . 
Secorrlary inm.me serum was diluted 1 : 50 for IgM assays and 1 : 200 for 
IgG assays. Triplicate assays of a reference serum diluted 1 : 50 to 
assay IgM and 1 : 200 to assay for IgG were perfonned. Plates were 
incubated two hours at roam temperature in a humidity chamber . After 
washing three times with 300 uL Trisjtween, 100 ul of 1 : 1000 alkaline 
PlosPhatase labelled goat anti-:rcouse IgG (Sigma ) or anti-mouse IgM 
(Sigma) diluted with Trisjtween containing 0 . 1% bovine albumin were 
added to all wells . Plates were incubated for three hours at room 
temperature in a humidity Chamber. · Plates were washed three times 
with 300 uL. Trisj'!Ween (pH 7 . 4 ) and 100 ul. of 1 rrgjml p-nitrophenyl 
phosphate, disodium (Sigma)· in 0 . 97% (vjv) diethanolamine buffer, pH 
9 . 8 ,  were added to all wells . Following thirty minutes o£ in�tion 
at roam temperature, the enzymatic reaction was stopped with 50 ul. of 
3N NaOH. Absorbance was detennined at a wavelength of 410 nm using a 
Microelisa Minireader MR590 (Djnatech) • 'Ihe average absorbance of 
the control wells for each serum was subtracted from the average 
absol:bance observed in the SRBC coated wells and this value was used 
to canpare the responses . Absorbance was corrected according to the 
reference serum as described by Voller, et . al . (78 ) . 
m.o. Ivnphngyte Proliferatiat 
m .  0.1. Collect.:i.cn· of serum 
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Blood fran AY;a 42-da.y, AY;a 120-day, aja 42-day, ani a;a 
120-day C57BI/6J female mice was obtained fran the subclavian artery 
durirg tenn:inal �tion. Serum was rerocwed following 
c:oagulation ani centrifugation at 500 X g on a Sol:Vall RI' 6000 
refrigerated centrifuge (DlPont, Wilmington, Delaware) usirg an H-
1000 rotor. Sera fran each group were pooled, filter sterilized 
us� 0 . 22 um Acrcdisc (Gellnan Sciences , Ann Arbor, MI) ani stored at 
-2o0c . until use . 
m . o. 2 .  P.roliferatiat Assay 
Mitogen in:iuced lyqilocyte proliferation assays were per­
fanned usirg a phenol extract of lipopolysaccharide (I..PS) obtained 
fran E .  coli 055 : B5 ,  concanavalin A (Con A), arrl phytohemagglutinin 
fran Rlaeseoulis vulgaris (:RiA) . Preliminary assays det'OC)nstrated 
optimal mitogenic activity at the followi.rg concentrations : LPS 
(Sigma) - 20 u.gnVml ; Con A, Type IV-S (Sigma) - 2 u.gnVml ;  and FHA 
(Sigma) - 4 u.gnVml . 
Spleens were aseptically reooved from each mouse , dispersed 
through a size 50 stainless steel mesh (Small Parts 1 Inc . 1 Miami , 
Florida) arx:1 suspe.rrled in a :minllnal volume of RfMI 1640 (Signa) with 
50 ngjl gentamycin (Sigma) . rue to the quantity of cells required, 3 
spleens from the same genotype arx:i age group were pooled . Clumps 
· fran the pooled spleens were allowed to settle for ten minutes . The 
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supernatant was reiOOVed arrl centrifuged at 200 X g for 10 minutes in 
a Sorvall Rr 6000 refrigerated centrifuge using a H-1000 rotor . 
Spleen cells were resusperded in approximately 5 ml RFMI 1640 
supplemented with 50rrg/l gentamycin (Sigma) , 1 mM sodium pyruvate 
(Sigma) , an:l 2 1rM L-glutamine (Flow Laboratories , McLean, VA) . 
Viability counts were perfonned using trypan blue exclusion dye and 
an Improved Neubauer (C .A.  Hausser & Son, Philadelphia) hemo­
cytometer. Prior to incubation, the cell suspension was supplemented 
with serum to a final concentration of 10% (vjv) . Serum supplements 
included sera obtained from the four groups of mice as well as CPSR-2 
!aN-mitogen bovine senim (Sigma) . 
'IWo hurxired microliters of each diluted cell suspension with 
the appropriate sennn supplement were added in quadrupl icate to 
sterile 96-well flat-bottomed tissue culture plates (Con1ing , New 
York) .. Control arrl treatment wells were seed  with 200 ul of cells 
at concentrations of 9 X 106 an:l 3 X 106 cells/ml for ll'S . and FHAjCon 
A controls ,  respectively . Fifty microliters mitogen at 100 ugm/ml , 
10 ugnv'ml , and 20 ugmjml of LPS ,  Con A, and FHA , respectively, were 
added to appropriate wells .  An equivalent volume of RfMI was added 
to control wells . 
Cells were placed in a humidified Precision Automatic co2 
incubator (GCA) and incubated for 48 hours (as detennined by pre­
liminary screens) at 370c. and 5% m2 prior to pulsing . Cells were 
pulsed with 1 · ul 6-3H-thymidine ( 2Cijmmole, Amersham Interna:tional) . 
TWenty hours · follotVing addition of the label , cells were hcuvested 
with a Brandel Cell Harvester (Gaithersburg, MD) on Brandel FP-201 
filter discs an:i placed in Minivials (New England Nuclear) . After 
air-drying, fi�e milliliters of scintillation cocktail ( 1  liter 
Triton X-100 ,  2 liters scintillation grade toluene, 1 . 5 gm 2 , 5-
diphenyloxazole (Fisher Scientific) , an:i 0 . 5  gm p-bis- (2- (5-
phenyloxazolyl) )  -benzene (New Englarx:l Nuclear) . Vials were stored 
at 4°c.  for at least 45 minutes prior to counting on a Beckman 
IS 1801 scintillation cotmter. Counts were perfonned for five 
minutes and recorded as mnnber of COlUlts per minute ( cpm) • 
m .E. statistical Ana.lvsis 
Least squares analysis of variance using the F-test . (F0 . 05 ) 
was used to evaluate significance . 
4 0  
IV.A. Weight � 
IV.A. 1. Total Body Weight 
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Forty-two-day-old arrl 120-day-old A'l;a and aja mice were 
weighed to verify the putative correlation between age and the onset 
of· obesity noted in 120-day-old A'lja mice (Table 1) . '!he average 
weights of 120-day-old A'l;a and aja (ISMean = 25 . 75 g ;  where ISMean = 
Least squares mean) mice were significantly (p<0 . 01)  greater than 
that of their 42-day-old counterparts (ISMean = 17 . 94 g) . While 42-
day-old A'l;a mice did not differ significantly in weight from 42-
day-old aja mice , the mean weight of 120-day-old AYja mice was 
significantly greater (p<0 . 01) than that of 120-day-old aja mice . 
IV.A. 2 .  0J:gan Ratios 
'!he size of the major lynphoid organs is often used as a 
general indicator of inununocompetence. 
. 
'!Wo of these organs , the 
spleen and the thymus , were reooved from 120-day-old and 42-day-old 
A'l;a and aja mice and weighed. '!he weights of these organs were 
corrected to the average body weight of mice within the age and 
genotype set (Table 1) . 
'!he corrected spleen weights did not differ significantly 
among the groups . 
'lhymus weights differed significantly (p<0 . 01)  between the 
two age . groups . 'Ihymus glands frcin 120-day-old mice were 
· significantly smaller (ISMean = 0 . 052 g) than were thymus glands 
Table 1. Table of Total Body Weight ani Relative Organ 
Weigh-o;a for 42-day-old arxi 120-day-old AY ;a 
ani aja mice. 
Total Body Spleen 'lhymus 
Weight (g) Weight (g) Weight (g) 
· 42-day-old aja 17 . 83° 0 . 096 0 . 07le 
42-day-old !3;a 1s . osb 0 . 099 0 . 067e 
120-day-old aja 22 . 22c 0 . 094 o . ossf 
120-day-old 13 ;a 29 . 28c, d 0 . 100 0 . 049f 
"weights corrected to the average body weight within 
the specified set. 
b ' c 'drthose not sharixg same superscripts have 
significantly different (p<O . Ol) body weights . 
e, Lrbose not sharirg same superscripts have signfi­
cantly different (�0 . 01) relative· thymus weights . 
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rerno_ved from 42-day-old mice (I.SMean = 0 .  069 g) . While 
nosignificant difference was observed between thymus weight and 
genotype, a trerxl was noted in which thymus glands from AYja mice 
were smaller (I.SMean = 0 . 058 g) than those from a;a mice (ISMean = 
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0 .  063 g )  with significance in this difference established at the 0 .  10 
level . 
IV. B. In vivo Cell-Mediated Inmmity 
. Delayed-type hypersensitivity (DIH) against CNFB was used as 
an in vivo determination of cell-mediated immunity . One of the 
requirements for initiating a DIH reaction is exposure to an 
initial , or sensitizing, dose of antigen. 'Ihe specific recruitment 
of cells does not occur after initial exposure to the antigen but 
requires a second exposure .  Upon secorrl exposure , or challenge , with 
the same antigen , a DIH response can be invoked . '!his is detected by 
the specific recruitment of effector cells to the site of antigen 
challenge. In this assay, cellular infiltration of in vivo 
labelled 125r cells was used an irrlicator of DIH reactivity against 
the skin contactant, rnrn . Control mice did not receive a 
sensitizing dose of rnrn . Result$ (Figure 1) were recorded as a 
ratio of connts per minute (cpm) in sensitized ear; cpm in control 
ear. '!he significant difference (p<0 . 01) in this ratio between 
sensitized mice (I.SMean � 3 . 23 )  and control mice (ISMean = 1 . 09 )  · is 
an irrlication of the specific recruitment of cells to the s�ght of 
antigen challenge, thus verifying this as a test of immunologic 
COMPARISON IN DELAYED HYPERSENSmVITY TO DNFB 
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Figure 1. Graph of Delayed Type Hypersensitivity (mH) 
between female CS7BI/6J yellar� (AY/a) arxi black· (aja) 
mice as detennined by the recruitment of 125!-labelled 
cells to the site of the I:NFB chal:lerge, i. e. the right 
ear . DIH reactivity is measured as a ratio of cpn in 
dlalletged ear divided by cpn in CXJittXol ear. Treatment 
groups received a topical application· of � five days 
prior to the challeBJe. Control mice did BJt :receive an 
initial sensitizing dose of I:NFB. Recruitment of 
effector cells to the rnFB c:hallen;Jed ear was 
significant. Control mice deoonstrated no specific 
recruitment as indicated by a ratio of 1.  A significant 
difference in IJIH activity between AY arxi a;a mice has 
been determined (p<0 . 05) . 
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specificity. Results also irrlicate that sensitized black (aja) mice 
respomed with significantly greater reactivity (p< . 05) (ISMean = 
3 .  56) than their sensitized, congeneic, yellow (AY ja ) littennate 
(ISMean = 2 . 96) . While the 120�y-old mice were slightly less 
responsive to a DIH reaction when compared to 42-day-old mice , no 
significant differences in DIH reactivity were obseJ::Ved between age 
groups within either genotypic set (Table 2) . 
Table 2 .  Comparison of DIH among 120-day-old 
and 42-day-old AY;a and aja female 
C57BI/6:T mice. 
42�y-old 
120-day-old . 
AY;a 
3 . 18a , b  
2 . 74 
aja 
3 . 65 
3 . 48 
� in sensitized earjcpm in control ear 
bvalues represent means of the ratios . 
IV. C. In vivo Hl.JIOOral Inm.mity 
IV. C. l .  Antilxxiy-fonnil'g CElls (AFC) 
B-cell reactivity aiOOI'lg' the four sets of mice was compared 
using a direct hemolytic plaque assay to quantitate SRBC specific 
antil:x:x:ly fanning cells . Figure 2 represents the number of antibody­
fanning cells per 106 spleen cells after either a primacy or 
seconc:IarY exposure to SRBC . With the exception of the 120-day-old 
yellow (AY/a) mice, the peak response following primacy exposure to 
SRBC occurred on the fifth day :p::>st-inununization . A peak res-pJnse 
NUMBER OF ANTffiODY FORMING CELlS TO SRBC 
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Eigure 2 .  Number of antilxxiy-fonnin; celJs · to the T­
deperxient antigen, sheep red blcxxi cell (SRBC) as 
dStennined by the direct heoolytic plaque assay. Values 
shown are the geanetric means for six mice. Female · 
CS7BII6J' AY/a ani a; a mice were irij ected 
intraperitcneally with 1 X 109 SRB:. Assays .were 
perfonned an days 4 ,  5, 6 , ani 7 (4p, Sp, 6p, ani 7p) 
following primary exposure of the antigen. Mice were injected three times at �y int:ava1s to in:iuce a 
sec:cnJaey response to the antigen. He.nclytic plaque 
assays were perfonned an days 4 ,  5,  6,  arxi 7 ( 4s , Ss , 
6s , ani 7s) after the third injection of the antigen. 
4 6  
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was not apparent am:>ng the 120-day-old yellow (AY/a) mice . 
Furthenrore, the overall primary response of the 120-day-old 
yellow(AY/a) mice was substantially reduced in comparison to the 
other groups . A typical decline in the number of AFC ' s  was noted 
among both the 42-day-old A'l;a ani aja arrl the 120-day-old black 
(a/a) mice following day 5 while the response observed with the 120-
day-old yellow (A'l/a) mice appeared to plateau . 
:Results indicate a significant (p< . OS)  decline, overall , in 
the total number of SRBC-specific AFC '  s from the primary response 
(I.SMean = 20 . 08 ) to the seconJary response (ISMean = 10 . 48 )  . As was 
observed during the primary response , the lowest response day for 
the four groups of mice was day 4 post-imnunization following the 
seconJary exposure to the· antigen. While the number of AFC '  s 
prcxiuced by the 120-day-old yellow (A'l/a) mice was slightly higher 
than that produced by the mice in the three other groups on the 
fourth arrl fifth day post-secorrlary exposure , these results were not 
significantly meaningful . 
IV. C. 2 .  Erlzylle :I�Im.Jrn:lssay (EIA) 
IV. C. 2 . a. Primary response . 
An EIA was perfonned to determine the relative levels of 
antigen-specific IgM ani IgG in the sera from the four sets of mice 
following a primary expoSure to the T-deperrlent antigen, SRBC .  
Figure 3 represents the · relative Concentrations of IgM on �ys 4,  5 ,  
6 ,  ani 7 post-immunization. A significant increase in the overall 
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Figure 3 . Relative levels of anti -sRBC IgM in serum of 
female · cs7BI/6T A'l;a ani aja mice an days 4 ,  5 , 6 , ani 7 
followirg intraperitoneal injection of 1 X 109 � as 
detennined by EIA usirg alkaline !ilosphatase labelled · 
anti -IOOUSe IgM. Serum was diluted i: 25 . 
· 
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IgM titer (p<0 . 05 )  was noted among 120-day-old yellow (AYja) mice 
(ISMean=0 . 53 )  when c:xxrpared with their 42-day-old counterparts 
(ISMean=0 . 34 )  or their 42-day-old ani 120-day-old congeneic black 
( aja) counterparts (ISMean=O. 35 ani o . 27 , respectively) • 49 
With the exception of 120-day-old yellow (AY/a) mice, peak 
levels of IgM occurred 5 days post-immunization arrl dropped 
dramatically on day 6 post-immunization. 'Ihe level of serum IgM in 
120-day-old yellow mice was markedly- higher than other groups on days 
6 am 7 post�immunization. '!he IgM level obsel:ved in the other three 
groups of mice appeared to plateau between days 6 am 7 .  However I 
the level of serum IgM in 120-day-old yellow mice did not drop after 
the f.ifth day, post-immunization. F\.lrthennore, the level of sennn 
IgM was significantly hi9her (p<O . 05) in 120-day-old yellow (AY ja) 
mice than that of the other three sets of mice. Levels of IgM in 42-
day-old yellow (AY/a) mice did not differ from those obsel:ved in 
black ( aja) mice. 
A comparison of the relative Combined levels of IgG on days 
4 1 5 1  6 1 and 7 after a primary exposure to SRBC revealed a 
significantly lower level of IgG in 120-day-old black (aja) mice 
(ISMean = o . 16)  when c:xxrpared to its 42-day-old black counterpart 
(ISMean=0 . 40) . As shown (Figure 4)  1 levels of serum IgG in 120-day­
old black (aja) mice were below those observed in the other three 
sets of inice on days 4 ,  5 ,  6 1  an:i 7 ,  post-innnunization. Overall , 
IgG levels in yatmg black mice were not significantly different from 
young yelloW (I.SMean = 0 . 39 ) nor old yellow (I.SMean = 0 . 3 1) mice . 
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Figure 4. Relative levels of anti-SRBC IgG in serum of 
female C57BII6J !3;a and a;a mice on days 4, 5, 6, ani 7 
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determined by EIA us,ing alkaline Iil06P1atase labelled. 
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IV. C. 2 .b. Seconda+y Response. 
51 
Relative levels of antigen-specific IgM arrl IgG were 
similarly campared following a secorx1aJ::y exposure to SRBC. Figure 5 
illustrates the relative levels of IgM on days 4 ,  5 ,  6 ,  and 7 
following a third injection of SRBC . Statistical analysis indicates 
no significant difference in overall IgM titer between yellow (AY /a) 
mice (ISMean = 0 . 91) arrl black (a/a) mice (ISMean = 0 . 64 ) . 
Data (Figure 5)  also illustrates a significant difference 
{p>0 . 05)  between age of the mice arrl peak response day following a 
secondary e.xp:>SUre to the antigen. Forty-�y-old yellow (AYja) 
arrl black {a/a) mice deiOOnstrated a peak IgM titer on the sixth day 
post-immunization while 120-day-old yellow {AY/a) arrl black (a/a) 
mice peaked on the fifth day post-immunization. 
Figure 6 illustrates the levels of IgG on days 4 , 5 ,  6 ,  and 7 
following a third injection of SRBC . With the exception of young 
yellow mice, levels of IgG gradually rose from the fourth to the 
sixth day post-immunization arrl dl:� from the sixth to the seventh 
day. No correlation between age arrl day of peak response was 
obsel:ved. Levels of IgG obsel:ved in the young yellow mice were 
erratic with a sharp peak obsel:ved on the s_ixth day, post­
immunization. No significant differences in IgG levels during a 
secondary immune response were observed among the four sets of mice 
analyzed� 
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Figure 5. Relative levels of anti-SRB: IgM in serum of 
. female C57BI/6J AY;a and a;a mice an days 4 ,  5 , 6 , and 7 
following a third intraperitoneal inj�an of 1 X 109 
SRBC as detennined by EIA us:irg alkaline pxsphatase 
labelled anti -rocruse IgM. Serum was diluted 1:  50 . 
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Figure 6. Relative levels of anti-SRBC IgG . in serum of 
female CS7BI/6.J �;a arxl a;a mice on days 4 ,  5 ,  6 , and 7 
following a third intraperitoneal injection of 1 X 109 
SRBC as detennined · by EIA usin;J alkaline tnosPhatase 
labelled anti-ItDJSe IgG. Sennn was diluted 1: 200 . 
IV. D. In vitro Mitogen--Irrltvm I¥nrilqr;yt;g Proliferation 
54 
In vitro mitogen-in:iuced lymphocyte proliferation assays 
using LPS ,  Con A,  an:i PHA were perfonned to assess the overall 
capacity of the lymphocytes to resporrl to polyclonal mitogenic 
stimulation. LPS is known to specifically stimulate B-cells . 
Likewise , FHA arrl Con A specifically stilnulate T-cells . '!he effects 
of genotype and age-related factors on the proliferative activity of 
the lymphocytes were canpared. 
IV. 0. 1 .  CCUparisan between geDJtype arxl age .  
Mitogen-induced lymphocyte proliferation assays are 
routinely conducted in media supplemented with fetal calf serum . 
In order to investigate the possibility of environmental influences 
on lynphocyte reactivity, lymphocytes were cultured both in the 
presence of fetal calf serum, known to provide optimal growth 
- COrrlitions 1 and in meclia supplemented With serum from the four Sets 
of mice. 
A comparison of the overall proliferative activity between 
the two genotypes (Figure 7)  during all culture conditions indicates 
that lymphocytes from genetically yellow (AYja) mice tended to be 
less reactive than that obseJ::ved with their congeneic black ( aj a )  
littennates . Although this difference was not significant for the 
LPS arrl · con A res:p::>nse ,  lymphoocytes from yellow (AYja) mice were 
EFFECTS OF THE A y MUTATION 
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Figure 7. stim1l ation :iniices (cpu of mitogen 
Stimulated eel 1 sjcpm of CCitl:Lol cells) of lyq;i1ccytes 
fran female C57BII6J' Ai;a ani . a;a mioa cultured in the 
presence (sti.nulated} or absence ( wnb:ol} of IPS ,  Con A 
ani BiA. Proliferation was detemined 1Jy the the uptake 
of 3H-thymidine. 'Ihis figure represents the <XI1pilation 
of results of cells cultured separately in fetal bcvine 
sm:um ani serum fran 42- ani 12�y-ald AY ;a ani a; a 
mice . 'lbe values shown for the mitcqen, PHA, are 
statistically significant (p<O . OS) . 
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significantly less reactive (p<O . Ol) to mA than were lymphoocytes 
from their congeneic black (a/a) littennate. 
56 
No consistent correlation between age and lymphocyte 
reactivity was observed (Table 3 ) . 'nlere were , however,  significant 
effects of age on lymphocyte activity when age groups were compared 
·within arrl between the two genotypes (Table 4 ) . Analysis of the 
proliferative responses of the lymphocytes to the three 
mitogensreveals a significant effect: of age in response to the B-cell 
mitogen, LPS . Lymphoocytes from 42-day-old black (a/a) mice 
resporrled with significantly (p<O . OS)  less intensity (ISMean=9 . 06) than 
120-day-old black (a/a) mice (ISMean=14 . 48) . AYja mice did not 
duplicate this trend . '!he response of lymphocytes from 42- and 120-
day-old yellow (A'l/a) mice did not differ significantly from each 
other. 120-day-old yellow (A'l/a) mice responded with significantly 
less intensity (ISMean = 8 . 12 )  than 120-day-old black (a/a) mice 
(LSMean = 14 . 48 ) . 
Mitogen-st.inn.llated proliferation assays in the presence of 
fetal calf serum revealed a decrease , albeit not significant , in 
lymphocyte reactivity towards LPS , Con A, and mA among yellow 
(A'l fa) mice when compared with their comeneic black ( aja) 
mice (Figure 8 ) . Young 42-day-old yellow (AYja) mice appeared to J:Je 
less reactive to Con A arrl FHA than were the other groups of mice . 
Table 3 .  canparison between . age am lynptocyte 
reactivity to B-cel.l ani T-cel.l 
mitcgens aD:ll'g }3ja ard aja C57BI/fJ 
mice. 
usa Con A5 :EHA5 
42-day-old . 9 . SC  4 . 4  4 . 1 
120-day-old 11. 3 4 . 6  3 . 4  
aB-cell mitogen 
�1 mitogen 
.Cc;m c.3H�dine> in mi� !:imlated wells 
cpn ( H-'Ihymidine) in cxuitz:ol �ls 
Table 4 .  �ction between age groups within 
genotype in response to B-cell ani T­
cell mitcgens. 
_bY/a a/a 
Hi_tcgen 42-da:l-old 120-da�-old . 4�-&.�-old �o-da�-old 
rmb 10. o5a 8 . 12  9 . 06 
Con Ac 3 . 54 4 . 16 5 . 22 
FHA.c 2 . 85 3 . 19 3 . 88 
Clcgn c3H�ctinef in mitcsen stimulated TNells 
cpn ( H-'Ihymidine) in cxmt.rol wells 
bs-ciu1 mitogen �1 mitogen · 14 . 48 5 . 13  5 . 02 
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COMPARISON OF MITOGEN INDUCED LYMPHOCYTE PROLIFERATION 
BETWEEN A y /a AND ala MICE 
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Figure 8. stllnulation iniices (cpn of mitogen 
stinulated cells/cpn of CXJJtl:Lol cells) of lyqJhocytes 
fran 42- an:l 120-day-old female C57Btl61 �/a am a;a 
mice in response to I.PS ,  Con A, ani HiA when cultm:ed in 
the presence of fetal bovine sennn. Proliferation was 
detennined by the incorporation of exogenoos 3H­
thymidine. Values Shown represent · no significant 
difference in responsiveness � the  four groups of 
mice. 
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IV. D. 2 .  Effects of syrgeneicjcageneic serum. 
59 
Syngeneicjcongeneic sennn from both age groups were tested 
to detennine possible inununarocx:lulato:cy factors. The effects of these 
four sera were tested on lymphocytes from the four sets of mice in 
response to FHA, Con A, arrl I.PS (Figure 9) .  OVerall lymphocyte 
proliferation was significantly less (p<0 . 01) when culture::l in the 
presence of sennn obtaine::l from the four groups ·of mice than when 
cultured in the presence of fetal calf sennn . The proliferative · 
response of splenocytes to FHA was markedly inhibited when they were 
cultured in the presence of serum from 120-day-old yellow (AYja) 
mice when compared with lymphocytes cultured in media supplemented 
with any of the other three pools of serum . The suppressive effect 
observed with serum from 120-day-old yellow (AYja) _mice (ISMean = 
1 . 28 )  was significantly greater (p< . 05) than that observe::l with serum 
from 120-day-old black (aja) mice (LSMean = 2 .  74 ) and serum from 42-
day-old yellow cAY/a) . mice (LSMean = .2 .  74) but did not sign�ficantly 
differ from the response obsel:ved in the presence of se:rum from 42-
day-old black ( aja) mice (ISMean = 1. 9)  . 
Analysis of lymphocyte reactivity in response to Con A 
(Figure 9)  revealed the apparent suppressive effect of serum from 
120-day-old yellow (AY/a) mice when compared with the proliferative 
response of lymphocytes cultured in the presence c:>f serum from the 
other three groups of mice. Lymphocytes cultured in sera obtained 
from 42-day-old yellow (A'l/a) arxl black (aja) , and 120-day-old black 
mice resporrled with sllnilar intensity. 
EFFECTS OF SERUM FROM 42-DAY-OLD AND 120-DAY-OLD 
AT /a AND a/a MICE 
ON MITOGEN INDUCED LYMPHOCYTE PROLIFERATION 
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Figure 9 .  Lymphocytes fran 42-day-old � 120-day-old. 
a;a ani A'l;a mice were cultw:ed in serum obtained from 
·these mice. Proliferation was detem:ined by 3H­
thymidine uptake, wherein the stinulation :irxlex = . 
cpu of mi tcgen stllnulated cells/ q:m of cxmt:rol eel l s.  
Values shown for each sennn supplement include the 
cc.rcpilation of data of lymphocytes obtained fran the 
four groups of mice. 
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A c:arrparison of the effect of these four sera on the 
proliferative response to LPS is shown in Figure 9 .  Lymphocytes 
cultured in serum fran 42-day-old yellOVl (A'Ija) mice responded with 
the greatest intensity while lymphocytes appeared to be least 
reactive when cultured in sennn from 120-day-old yellOVl (AY/a) mice. 
Figures 10 through 12 represent the differential effects in 
lymphocyte proliferation between the four groups of mice when 
cultured in the presence of the three mitogens and with sennn 
obtained from the four sets of mice. Lymphoocytes from 120-day-old 
black (aja) mice were markedly 100re responsive to FHA (Figure 10) when 
cultured in serum from their own sennn . '!his enhanced response was 
significantly reduced when the· lymphoocytes were cultured in serum 
from 120-day-old yellOVl (AY/a) mice. Furthennore , �lenocytes from 
120-day-old black (aja) mice deltonstrated a mar� proliferative 
response to LPS when conprred with the other three sets of mice 
(Figure 11) . Again, this effect was obviated when cultured in the 
presence of sen.nn from 120-day-old yellOVl (A'f /a) mice. Finally, �e 
increased responsiveness obsel:ved in 120-day-old black (a/a) mice to 
PHA arxi LPS was not obsel::ved in response to Con A (Figure 12 ) . · 
Lymphoocytes from 120-day-old yellow (AY /a) mice tended to be 
least reactive to the three mitogens when cultured in serum obtained 
from 120-day-old yellow (AY/a) mice (Figures 10-12 ) . Enhanced 
reactivity of these lymphocytes to LPS appeared to occur when these 
·cells were cultured in sennn from the other three sets of mice 
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Figure 10. Lymphocytes fran 42- arxi 120-day old female 
C57BII6J AY;a ani aja mice were cultured separately in 
the presence of serum fran 42-day-old a;a mice (YBS) , 
120-day-old aja mice (OBS) , 42-day-old AY;a mice (YYS) , 
ani 120-day-old AY;a mice (OYS) . 'Ihe proliferative · 
response of the lymphocytes to the T-cell mitogen, 
phytohemagglutinin (FHA) , was detenninecl · thrcugh the 
incorp:>ration of 3H-thymicline. Values sham represent 
the stimulation irrlex (cpm of .mitogen stimulated cells/ 
cpm of control cells) • 
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EFFECTS OF AUTOLOGOUS SERUM 
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Figur:e 11. Lynphocytes fran 42- am 120-day old female 
CS7J3II61 A'l fa ani a; a mice were cultm:ecl separateUy in 
the presence of serum fran 42-day-old a;a mice (YBS) , 
120-day-old aja mice (OBS) , 42-day-old A'l;a mice (YYS) , 
ani 120-day-old A'l;a mice (OYS) . '!he proliferative · 
response of the lymphocytes to th8 T-cell mitogen, 
Concanavilin A (Con A) , was dete.nnined through the 
irxxn:poration of 3H-thymidine. Values shown represent 
the stimulation in:iex (cpn of mitogen stimulated 
cells/cpm of control cells) • 
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EFFECTS OF AUTOLOGOUS SERUM 
ON CON A INDUCED LYMPHOCYTE PROLIFERATION 
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Figum · 12 .  Lyq;ilocytes fran 42- am l2�y old female 
CS7BII61 A'l/a am a;a mice were cultmed- SE!parately in the presence of serum fran 42-day-old a; a mice · (YBS} , 
120-day-old a;a mi� _ (OBS} , 42-day-ol.d IY;a mice (YYS} , ard 120-day-old. A'l;a mice (OYS) . · 'Dle proliferative response of the ·lyrrphocytes· to the B-oell mi�, ·rm , was detenn:i.ned through the iro:n:paratial of 3H­thymidine. Values shown represent the . stim1l a:tian in:iex 
{cpu of mitogen stimulated o:all sjcpn of catll:ol. eel J s} • 
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(Figure 11) . However, this enhancement was not apparent with 
respect to FHA arrl Con A (Figures 10 and 12 ) . 
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v. Weight Q"!tparison 
V.A. 1 .  Total Body Weight. 
v. 
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Total body weights between 42-day-old and 120-day-old yellow 
(AYja) and congeneic black (aja) mice were compared to verify the 
correlation between age and the onset of obesity in lethal yell'ow 
(AY) mice. '!he mean weight of 120-day-old yellow (AY/a) mice 
differed significantly from 120-day-old black (aja) mice . Moreover,  
the total body weight of 42-day-old yellow (AYja) and black (aja) 
mice did not differ. '!his indicates that an age-associated obesity 
has segregated with the A'l;a mutation. Since obesity has been 
demonstrated to be associated with inunune dysfunction, tests of 
immune function were peifonned on 42-day-old yell0\\7 (AYja) while they 
were lean arrl compared with data obtained at the onset of obesity . 
Age�matched lean, black congeneic (aja) littermates were used as 
controls .  
V.A. 2 .  Lynploid Organ Weights 
Evaluation of the immune system often includes a gross 
examination of the lymphoid organs from which immunologically 
competent immune cells arise (79 ) . Aloong the most cormnon points of 
examination include thymus and spleen mass . 
'!he thymus is a priJnary lymphoid organ in which maturation 
arrl differentiation of T-cells cx:::cur . · Results indicate a 
significant decrease in relative thynrus weights with an increase in · 
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age . '!his correlation was expected because thymic involution after 
puberty is typically· observed ( 69) . Unlike thymic depletion of 
neonates which leads to the impainnent of T-cell-mediated inlmunity, 
adult thymic involution does not usually affect immune function. 
While not statistical.ly significant (p< . 05) the relative thymus 
weights of yellow (A'l/a) mice tenied to be less than that of their 
congeneic black (aja) littennates (p< . lO) . '!his may have an impact 
on cell-mediated immunity since the- thymus is the prllnary organ of T­
cell maturation. '!he thymus also acts as an endocrine gland 
secreting ho:rTOC>nes that are important in T-cell maturation. 'Ihese 
include thymosin, thyxoopoietin, arxi thymic humoral factor. Depletion 
of this prllnary organ would therefore lead to fewer circulating 
mature T-cells ani , thus , an inpainnent in cell-mediated inlmuni ty. 
'!he spleen is a secorrlary lyttploid o� containing both B­
and .T-cells . However, it is often considered to be a major B-cell 
organ ( 69) . Relative. spleen wei9hts .did not differ amoilg �e four 
sets of mice studied. 'nlus, no apparent immunological aberration is 
indicated on the basis of relative spleen size . 
V. B. In vivo Ce.ll-medj ated Dmmrl:ty 
DIH was perfonned to compare in vivo cell-mediated :irnrnuni ty 
among the four sets of mice. Results indicated that the lethal 
yellow (A'l/a) mice were less responsive to tNFB than w� theh­
congeneic black (a/a) counterparts . SUppressed cell-mediated 
immunity a5 _detennined through DIH sensitivity seems to be directly 
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correlated with the 13 mutation arxi does not appear to be causally 
related to obesity. '!his conclusion is based on the obsavation that 
age, correlating to the onset of obesity in yellow mice , did not 
appear to influence UIH reactivity. '!his observation differs from 
data obtained in relation to the viable yellow mutation (Avy) , which 
occurs at the agouti locus an:i displays similar manifestations to the 
lethal yellow mutation. Studies perfonned on the viable yellow mouse 
using the skin contactant, oxalazone, showed no significant 
difference in om reactivity from that of their genetically identical 
lean littennate nor from their congeneic black littennate ( 59 ) . '!he 
differences noted between these studies on the A vy mutation and our 
studies may illustrate a differential e.ffect of the lethal yellow 
mutation in relation to the remarkably similar viable yellow 
mutation. However, this comparison nrust be U5e:d cautiously in that 
I:NFB, instead of oxalozone , was used in our experiment. Furthennore , 
om responses of the viable yellow mouse were measured through ear 
swelling which is not as sensitive as the radioisotope labelling 
perfonned in our experiment (74) . 
Since IJIH is a T-cell mediated inunune mechanism, an 
impairment in T-cell activity is ilnplicated in the lethal yellow 
(!3) nouse . Aberrations in T-cell activity have also been obsel:Ved 
by other investigators . Gasser ani Fischgrund (21) demonstrated 
decreased responsiveness in splenocytes from lethal yellow (AY) mice 
in a graft vs . host reaction when compared with splenocyt� from 
their congeneic lean, black (aja) littennates . our data indicate an 
alteration in the TDIH subpopulation of T-cells and therefore 
complements data presented by Gasser am Fischgnln:i (21)  which 
suggests alteration in the Tc subpc:p.tlation. Together these two 
studies de!Ironstrate the severity of the T cell defect. 
Alterations · in T-cel.l function may result from a mutation 
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at the A'l loci that may directly affect T-cell development or 
function. '!his would correlate with the observed decrease in thymus 
weights . Alternatively, suppressed- DIH reactivity may represent an 
alteration not directly associated with the T-cell population. Many 
cellular interactions occur durin;J the course of a T-cell mediated 
response . Processing of antigen prior to immunologic stimulation 
often requires presentation of· the antigen to the T4:ell by a 
macrophage. Antigen presentation requires proper cell to cell 
interaction which � believed to be regulated by the prcxiucts of the 
.imnune response genes . Hence, an alteration in the expression of the 
immune response genes _ may lead to improper interaction· and thuS 
decreased inununoreacti vi ty.  
On a broader scale, suppressed DIH reactivity may be the 
result of altered responses to factors released by cells during an 
immunologic response. Antigen-stimulated T-cells release 
lymphokines , such as macrophage chenotactic factor and migration 
inhibition factor that enable the specific recruitment of macrophages 
to the antigen-challenged site. 'lhese recruited cells also beCome 
activated through other lymphokines released by the antigen­
stintul.ated · T-cell . Activated macrophages, in turn , release factors 
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that further enhance T-cell activity. A decrease in synthesis or a 
st:J:uctural change in any of these various factors could lead to 
suppressed DIH activity by an interruption of the cascade leading to 
the DIH reaction. 
V. C. In vivo Hl.mDral. Illmmity 
In vivo .humoral immunity was assayed through the en'LUlleration 
of B-cells producing specific antibody to the T-dependent antigen, . 
SRBC . arrl through the measurement of serum SRBC specific IgM and IgG 
antibody levels . Hul'oc>ral immunity was monitored through a 
predetennined period of time in order to detect possible differences 
in both the time arrl extent of peak resporisi veness . Alterations in 
the peak response would ·indicate alterations in the regulation of the 
:innnune response. 
V. C. 1 .  Antibody-Fonni.rg <Pll s {AFC) 
Enumeration of direct heoolytic plaques revealed a 
substantially reduced number of plaque-fanning cells produced by the 
120-day-old yellow (A'I/a) mice on days 5 and 6 following a primary 
exposure to SRBC . Whereas the rnnnber of direct plaques peaked for . 
the lean, black controls arrl the 42-day-old yellow mice , a peak was 
not obsel::ved in the 120-day-old yellow (A'I) group . '!his may 
represent an .impainnent in the i.rrluction of antibody synthesis · or may 
irrlicate a delay in the peak reSponse to the antigen. '!his apparent 
suppression in antibody-fanning B-cells .may be a causally related to 
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obesity as 42�y-old yellow (A'l) mice resporxied similarly with lean , 
black (aja) mice. '!his correlation between the imm.me response and 
obesity in the A'! JOCJUSe  differs fran observations reported in a 
separate strain of obese mice. A silnil.ar study performed on 
genetically obese (ob/ob) mice ( 10 )  deltonstrated an enhancement, 
rather than a decrease , in the number of antilxxiy-fonning cells ' to 
SRBC in the obese IOOUSe when compared to the lean mouse . '!his 
suggests physiologic differences in- obesity between the genetically 
obese (ob/ob) nouse am the lethal yellow (A'l) mouse which may be a 
function of the mutation. 
With the exception of 120�y-old yellow (A'l) mice, a 
decline in the number of direct plaques was obsel:ved follOYling a 
secorxiary exposure to �. '!his decrease in the IlUitlber of direct 
plaques would be expected as a result of a switch in antibody 
synthesis from IgM to IgG. As mentioned previously, direct hemolytic 
plaque assays pennit only the quantitation of B-cells producing 
antibody of the IgM isotype . Since this decrease was obsei:ved in 
these three sets of mice, it is interestirg that the number of 
plaques did not decrease in the 120-day-old yellow mice . Unlike the 
three other sets of mice, the number of AFC ' s  produced by 120-day-old 
yellow mice generally remained the same during the secorxiary responSe 
as � to the number of AFC' s produced in the prllnary response . 
Several possible defects may account for this absel:vation. First, 
the plateau may iirli.eate di.nriniShed T suppressor activity 
Secorxily, it is possible that the obese yellow mice peaked at a later 
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time following the primary exposure to SRBC and then normalized to 
the levels abseJ:ved in the other sets . Finally, this delayed peak of 
imnrunological reactivity might irx:licate alterations in the regulation 
of the overall resp::>nse . '!he observed plateau may indicate a failure 
in isotype shift, a mechanism which is believed to be induced by the 
helper T-cell (33 ) . Failure in isotype shift would lead to 
dilninished IgG production, hence , in:ticating a defect in this T-cell 
population. An in:lirect plaque assay enabling the detection of AFC ' s  
producing IgG was attempted during our investigation. Unfortunately, 
an overall suppression of plaques was obseJ:ved upon the addition of 
anti-rrouse IgG to the lymphocyte culture , thus , invalidating the 
data. 'Ihi.s curious phenomenon has been obset:Ved by other 
investigators as well ( 3 1) . 
v. c. 2 .  Enzyme Illm.n'Xlassay 
Relative levels of serum IgM and IgG to SRBC were determined 
following both a primary arx:l secoOOal:y exposure to SRBC. 
Inexplicably, the serum anti-SRBC IgM level in 120-day-old yellow 
(A'l) mice following a primary exposure to the · antigen became 
significantly higher than the other three sets of mice . The 
incl:-eased IgM titer observed in this group of mice did riot correlate 
with the decr:eased ntnnber of IgM plaques fanned. These observations 
suggest that fewer B-cells are secreting higher concentrations of IgM 
antil:x:x:lies ,  thus, inplying an aberration in the regulation of 
antibody synthesis .· Because of this apparent aberration in the 
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regulation of antibody synthesis , the lethal yella;.v m:rlel may se:rve 
useful for studies in hypersensitivity reactions where a dysftmction 
in inmunologic regulation leads to a pathologic corrlition . 
'Ihe regulatory mechanisms of the immune response have not 
been fully elucidated. However, helper T-cells are believed to 
regulate the shift in isotype synthesis fran IgM to IgG. Without 
this shift, increased IgM levels without an increase in IgG would be 
expected. SUppressed function of the helper T-cell could be 
implicated in this investigation except that levels of serum anti­
SRBC IgG in the old yellow rrouse were equivalent to that observed in 
the other sets of mice. F\lrtherm::>re, i.npainrent of the helper T-cell 
function would also be associated with a failure to produce an 
anamnestic response since the helper T-cell is an integral part of 
this response. '!his was not the case as data indicates a secondary 
response in the 120-day-old yella;.v nouse statistically 
indistinguishable from the other mice� 
Because altered hl.llOOral activity was absenred only in 120-
day-old mice , obesity, rather than genotype, seems to be intimately 
involved in the control of this facet of the immune system. 
Investigations usi.m the viable yella;.v (Avy) model hcive also 
indicated that altered immunological function is a secondary effect 
of obesity rather than genotype. studies with the Avy model revealed 
that anamnestic IgG responses to a T-depenient antigen were 
significantly reduced in obese ,  viable yellow mice when � to 
their genetically identical , albeit phenotypically different, lean 
littennates (59)  . 'Ihus , this effect has been attributed to a 
seconJa:cy effect of obesity rather than the -effect of the gene 
nutation. rurirg our studies , a depressed anamnestic response was 
not detected in the lethal yellow neuse . Again, these contrasting 
obsel:vations suggest differences in the physiology associated with 
obesity obsel:ved a100ng different types of obese mice . 
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A significant effect of age on the antibody response to SRBC 
was noted following a seconJa:cy exposure to the antigen . However, . 
this effect was not asscx::iated with a genotype difference , and , 
therefore, is not pertinent to this discussion . 
V. D. In ·vitro Assessmelrt of the Tlimme Response 
In vivo tests of the immune system are often complicated by 
the degree of interaction that occurs between the systems within the 
body. 'Iherefore, in vitro tests are used to try to narrow the focus 
of possible aberrations . As pointed out, the lethal yellow mutation 
seems to be directly involved in suppressed cell-mediated immunity as . 
denK)nstrated by the DIH test . However, through this in vivo assay, 
it was not possible to detennine if the abnonnality was specifically 
associated with T-cell function. Conversely, htnnaral immunity does 
not appear to be directly affected by this mutation in that 
aberrations are only obsel:ved in 120-day-old yellow mice . Since 
these mice weigh significantly more than the other three sets of 
mice, obesity likely plays a role in the altered immune response 
obsel::ved in response to SRBC. To help ascertain the source of the 
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aberration, in vitro lymphocyte stinulation assays to polyclonal 
mitogens were perfonned. Mitogens that specifically stimulate B-cell 
am T-cell populations were chosen . Lipopolysacchari�e, a B-cell 
mitogen, am two T-cell mitogens, concanavalin A and 
phytohemagglutinin were utilized. 'Ibis test served two purposes , one 
to detennine if abnonnal lymphocytes are a result of genotype and the 
other to detennine if there is an effect of the physiologic 
envirornnent on lymphocyte reactivity. 
V. D. 1.  � Proliferaticn with Fetal BcNi:ne Serum 
Optimal growth corrli.tions for :mammalian cell culture 
requires the addition of sennn to the growth medium. 'Ihe most 
c::ornnnnly recognized senlm for IOOSt cell culture is fetal calf sen.nn . 
D.lring this study, lymphocyte proliferation assays were perfonned 
urxier such optimal growth c::orrli.tions . While mice bearing the lethal 
yellow mutation terxied to react with. less magnitude , nci significant 
differences were observed in the reSponse . . 'Ibis suggests that the 
lethal yellow mutation is not directly associated with the ability of 
lymphocytes to resporxl ·to these polyclonal stiJnul.ants . From these 
obse:tvations, suppressed DIH reactivity as a result of the A'l 
appears to be due to an alteration that is not directly associated · 
with T-cell function, but suggests defects in antigen presentation or 
regulation of T-cell activity. 
V.D.2 .  � Proliferaticn with cage.neicjSyrgeneic Sennn 
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Cell-mediate:i immunity studies performed by C1andra and Au 
( 10) using obese (ob/ob) mice inlicate that in-paired imnunity is the 
result of an abnormal physiologic environment. '!hey fourrl the 
reactivity after in vitro stimulation of spleen cells from obese mice 
·did not differ significantly from the reactivity of the cells 
obtained from lean controls. To ascertain the possible influence of 
serological factors in the response- of obese yellow (AY) mice in our 
study , lymphocytes were cultured in the presence of rnitogens using 
media supplemented with 10% sen.nn fran the four sets of mice . 
Interestingly, stllnulation inlices were significantly less when 
lymphocytes were cultured with col'l9eneicjsyngeneic sen.nn than when 
cultured with allogeneic fetal calf serum . other investigators have 
obsel:ved a similar immunosuppressive effect of autologous sennn 
( 49 , 75) . Veit arrl Michael (75) reported a suppression of antibody 
synthesis to SRBC when murine lymphocytes were cultureS in the 
presence of normal IOOUSe sennn . Unfortunately, this imnunosup­
pressive factor was not characterized. 
Inexplicably, differences between genotype became apparent 
durirlg the proliferative responses of splenocytes in the presence of 
congeneicjsyngeneic serUm to the various mitogens . When compared to 
their black (aja) controls (Figure 7 ) , lymphocytes isolated from 
yellow · (AY) mice revealed a significant difference in a�ivity . to the· 
T-cell mitogen, :RIA, when cultured in the five pools of � · PHA 
is known tO specifically stllnulate cells bearing Ly 1 ,  2 ,  3 surface 
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markers (51) which are foun:l on all urrlifferentiated T-cells . 'Ihis 
obseJ::vation suggests· either fewer numbers of lyqilocytes bearing the 
Ly 1, 2 , 3  marker or decreased sensitivity of Ly 1 , 2 , 3+ cells to this 
mitogen on Ai;a lymphocytes . A significant difference in response to 
the other T-cell mitogen, Con A, known to stimulate Ly 1+ cells , was 
·not observed. Since DIH T-cells bear this marker, one would have 
expected a decreased response to this mitogen. 'nlis indicates that 
the suppressed DIH response observed in this study is not 
intrinsically related to an aberrant T-cell population. 
Lymphocytes cultured in the presence of serum from 120-day­
old yellow (llY) mice appeared to be less reactive than the other 
groups of mice. '!his effect was IOOSt significant (p< . 05) in the FHA­
induced blastogenesis assay. Since cells cultured under optimal 
contitions, in fetal calf serum, did not display this effect, this 
suggests the presence of sane factor(s) in the serum of 120-day-old 
mice that may suppress the proliferative response of lymphocytes to 
this T-cell mitogen. Investigators have demonstrated. a correlation 
between the presence of lipids in serum am suppressed lymphocyte 
reactivity (27) . Cholesterol is an example of a lipid which haS been 
deoonstrated to exert inmmosuppressive effects. Reportedly, 
increased cholesterol within macrophages inhibits the phagocytic 
process , thus affect:inl its function in killing or processing antigen 
(76) . ·Failure to process antigen would likely lead to defective 
antigen-presentation to lymphocytes , inhibiting the immune response . 
'!be increased levels of cholesterol in the serum of obese yellow mice 
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(8) makes it tempting to speculate that this is at least partially 
responsible for this suppressive activity. In relation to this , the 
suppressed plaque-fonnation observed in response to SRBC in 120-day­
old yellow (A'l/a) mice may also be related to hypercholestrolenemia . 
While not statistically significant, cells cultured in the 
·presence of LPS ani cultured in sennn from 120-day-old yellow mice 
also tended to be less responsive. Since LPS specifically 
stilnulates B-lymphocytes , diminished reactivity of this population 
may also explain the decreased number of plaques observed in the 120-
day-old yellow mice. As observed with the PHA response of T-cell 
populations , lipids in serum have been reporterl to affect lymphocyte 
reactivity to LPS (27) . 
'Ihe Con A-irrluced proliferative response of lymphocytes 
cultured in the presence of serum fran 120-day-old (AY /a) mice 
appeared to be similarly suppressed. Con A specifically stimulates 
the subset of T-lymphocytes bearing the ly 1 marker . '!his 
subpopulation includes both the helper T-cell and the TDIH cell . If 
this population of T-cells were affected by factors in this sennn , it 
would be lCXJical to speculate that the intensity of a DIH reaction 
arrl the imnunolCXJiC responsiveness to T-dependent antigens , such as 
SRBC, would be significantly suppressed in 120-day-old mice . 'Ibis 
relationship, however, was not observe::i. SUppressed UIH activity in 
the lethal yellow nouse was not relate:i to obesity. 
V.E. Disparity Between In vitro ard In vivo Results 
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Upon comparison of the effects of autologous serum among the 
four groups of mice (Figures 10-12) , it was noted that lymphocytes 
fran 120-day-old black (a/a) mice were 100:re responsive to RIA and LPS 
than were lytrphocytes fran the other groups of mice, inticating 
heightened T-cell and B-cell reactivity. 'lhis was inconsistent with 
the significantly decreased anti-SRBC IgG titer obseJ:ved in this 
group of mice (Figure 4 ) . Speculatively, IgG levels produced by 120-
day-old black (a/a) mice may have peaked earlier than the fourth day 
following inm..tnization to SROC. If antil:xxly titer peaked earlier 
than day 4 ,  the rnnnber of plaque-fanning cells should also have 
peaked before the fourth day. However, heightened reactivity was not 
inticated by the results · from the direct hemolytic plaque assay where 
peak responsiveness occurred on the fifth day post-ilmtunization 
(Figl.lre 2)  . 
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VI .  cmcrnsiW 
Many complex physiological and immunological interactions 
are obset:Ved in the (AYja) mouse model . Da.ta demonstrate the 
influences of this mutation on the immunoreactivity of the lethal 
yellow mouse . Body weight rather than genotype per se appears to 
exert an immunomodulatory effect . nris was demonstrated in both 
ht.nnoral and CMI assays . Evidence for possibly depressed htnnoral 
immunity included decreased numbers_ of antibody-forming cells 
isolated from 12 0-d.ay-old yellow mice and the reduced responsiveness 
of lymphcx::ytes obtained from 120-d.ay-old yellow mice to the B-cell 
mitogen , LPS , when compared with the other groups . CMI responses 
also appeared to be influenced by factors associated with obesity . 
Sennn obtained from 120-d.ay-old yellow (AY) mice tended to suppress 
the proliferative response of lymphcx::ytes to both T-cell mitogens . 
other irregularities in cell-mediated immunity were directly 
associated with the AY mutation since the effects were ·apparent in 
both lean , as well as , obese yellow mice . . '!his was demonstrated in 
vivo in the IJnf reaction and , to a lesser extent , in vitro during 
lymphcx::yte proliferation utilizing T-cell mitagens . These 
observations further support the evidence of the influence of · the AY 
mutation on the immune system that has been reported in the 
literature ( 2 1 )  . 
Based on these · data , one can only conj ecture as to the direct 
or indirect role that the agouti locus plays in immunoregulation . 
'!he agouti locus is closely associated with many genes responsible 
8 1  
for immune regulation. 'Ihese genes include the H-3 ani H-13 , as well 
as several other, minor histoc::atpatibility loci (22 ) . Additional 
gene sequences of inm.mological significance associated with the 
agouti locus include the Ir-2 genes which ccx:le for such lymphocyte 
surface antigens as Ly-4 , Ly-mll (which is believed to be the gene 
that codes for B-2-microglabulin) , Ly-23 , Qam9 ,  arrl GM-3 , and finally 
�2 (which controls a cell surface glycoprotein of macrophages) 
(22)  . Hence , this cluster of genes - in the mouse may have a number of 
both . biological arrl inununological implications comparable to the 
widely studied MHC of chraoosame 17 (11) . since these genes are 
closely linked to the agouti locus , it thus seems plausible that a 
mutation at this locus may have an effect on these closely linked 
illlmunoregulatocy gene sequences . 
'!he lethal yellow mutation at the agouti locus has been 
associated with the absence of two of the three fonns of tyrosinase . 
Investigators believe that this is a .result of a glycosylation 
defect. On this assumption, one could speculate that the failure to 
glycosylate membrane proteins may also occur . '!his could result in 
an alteration of lymphocyte markers . '!his would explain the data 
obtained . during con A arrl PHA-in:iuced lymphocyte proliferation. 
Since PHA binds to the N-acetyl-glucoseamine group of glycoproteins ·· 
ani con A binds to -mannosyl ,  failure in the glycosylation of 
protein with N-acetylglucoseamine may account for the differences in 
birrlin;J and activation of the mitogens to the lymphocytes and , thus , 
explain the significantly suppressed response of the AY ;a lymphocytes 
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to :RiA. 'Ibis interpretation must be viewed cautiously, however. The 
observed increase in lymphocyte proliferation of 120-day-old black 
(aja) mice to RiA may be the contributing factors to the overall 
difference in activity between the two genotypes . However, data on 
lymphocytes cultured in the presence of fetal calf serum does 
in:ticate a decrease in reactivity cuoong AY;a mice. 
Speculative evidence for the alteration of one or more of the 
minor histocompatibility loci associated with the agouti locus is 
in:ticated in the literature. Of particular interest is an 
investigation pe.rfonned by Wolff (81) . His study involving the growth 
of AY;a arrl aja mice in parabiosis centered on the detection of 
possible honronal differences between these mice . His data may be 
interpreted to be of inumlnological significance . In control groups 
where yellow mice were j oined with yellow mice , or black mice joined 
with black mice , mortality ranged from 0-7% . On the other hard ,  when 
black mice were joined with yellow mice , mortality dramatically 
increased to 20-40% '!he majority of these deaths occurred three or 
100re months after the union of the mice in parabiosis . It is 
therefore possible that this may have been a result of graft 
rejection. An incompatibility in minor histocorrpatibility antigens , 
such as the H-3 , can be responsible for graft rejection . However,  
such rejection is usually much slower than that from incompatibility 
in the MHC ani may take longer than 100 days to occur . 
Coincidentally, deaths of the heterogenous pairs of mice in Wolff ' s 
parabiosis experiment occurred within 100 days . 
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A final interesting aspect of the agouti locus is the 
presence of a retroviral sequence referred to as Emv-15 , closely 
linked to the agouti locus ( 12 )  • Retroviruses can be integrated into 
host chraoosames arxi act as nutagens either by two mechanisms . '!hey 
can i.nternipt the nonnal gene expression of the host chrornosoine or 
activate the expression of cellular sequences flanking the 
integration sites (80) • 'lhus, the possibility exists that the 
insertion of this retrov:inls has altered the expression of one or 
100re .of these genes which play a role in imrmmoregulation. If an 
ill1mune response gene, which codes for Ia antigens , is inactivated, 
the Ia antigen will not be expressed on the lymphocyte . '!his would 
impair cell-to-cell interaction am lead to suppressed IJIH activity, 
as well as ,  other cell-mediated inmme mechanism . 
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VII . SlJlttt1ARY 
In sununation , the lethal yellow mutation appears to be 
causally related to diminished immunoreactivity . Unfortunately, it 
is not a straight-fonvard mutational effect. It appears that both 
the physiological environment which either causes or results from 
·obesity and the lymphocyte itself are altered as a result of this 
mutation . Whereas the obesity appears to be associated with the 
suppression of humoral immunity, direct effects of the mutation 
itself appear to be responsible for the reduced CMI response observed 
during the DIH reaction . Combined , these results provide another 
link between immunosuppression and cancer susceptibility .  
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